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Ca2+ oscillation is hallmark of mammalian fertilization that is thought to mediate egg activation 
process, and dramatic targeting of the endoplasmic reticulum (ER) to the microvillar subcortex, 
is known to provide calcium pools for subsequent activation and embryo development. While the 
mechanisms by which Ca2+ oscillation govern later embryonic development are poorly 
understood, emerging evidences indicate the critical role of Ca2+ oscillation in embryonic 
development, for example, by regulating recruitment of maternal mRNAs.  
Mater (Nlrp5) and Padi6 are oocyte-and early embryo-restricted maternal effect genes that are 
required for embryonic development beyond the 2-cell stage. Interestingly, PADI6 localizes to, 
and is required for the formation of oocyte-specific structure termed cytoplasmic lattices (CPLs).  
Based on similarity between MATER and PADI6, we hypothesized that MATER is also required 
for CPL formation. Indeed, ultrastructural analysis of Matertm/tm oocytes show ~90% reduced 
volume of CPLs and immuno-EM demonstrates the localization of MATER to CPLs, indicating 
MATER as a component of CPLs. Interestingly, Tubulin was also identified as a CPL 
component and that Tubulin interacts with PADI6. Given that Tubulin drives organelle 
movement, the role of Tubulin-PADI6-CPLs in organelle distribution during oocyte maturation 
was demonstrated.  
Given above observations, we further hypothesized that Mater plays a role in ER distribution and 
function, Ca2+ homeostasis in oocytes. We first investigated ER distribution by microinjecting 
DiI into oocytes and found that, as opposed to WT oocytes, the ER in metaphase-II Matertm/tm 
oocytes failed to concentrate around the spindle and cortical clusters were reduced. As cortical 
clusters are thought to be important for Ca2+ oscillation, then we tested if the pattern of Ca2+ 
oscillation is altered in Matertm/tm oocytes after in vitro fertilization. Intriguingly, Matertm/tm 
oocytes show altered Ca2+ oscillation pattern, lower amplitude and higher frequency. Then we 
demonstrated the reduced amount of intracellular Ca2+ stores in Matertm/tm oocytes, in part, 
contribute to such phenotype. Finally, the localization of IP3R-I, an essential player in releasing 
Ca2+ from ER, was altered in supporting of ER distribution. Taken together, this observation 
support the hypothesis that MATER is required for CPL formation and is involved in ER 
distribution and Ca2+ homeostasis in oocytes.  
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CHAPTER I 
INTRODUCTION	  	  
	   2	  
1. Overview of mammalian oogenesis and preimplantation embryogenesis  
Primordial germ cells (PGCs), diploid precursors of eggs, give rise to oogonia that mark the 
start of mitosis upon arrival in the female genital ridge. The oogonia mitotically divide and 
become primary oocytes upon entering meiosis. The primary oocytes remain arrested in 
prophase I of meiosis, defined as the germinal vesicle (GV) phase. Perinatally, primary oocytes 
are surrounded by a single layer of flattened granulosa cells to form primordial follicles. The 
granulosa cells change into cuboidal in primary follicles and then they proliferate to form 
multiple layers in secondary follicles. As oocytes continue to grow, they produce and accumulate 
substantial amounts of mRNA and proteins. Hormones stimulate the formation of tertiary antrum 
follicles with antrum and cumulus oophorus. Under the influence of hormones, oocytes resume 
meiosis I, go through germinal vesicle breakdown, and form secondary oocytes. Oocyte 
maturation proceeds to meiosis II and re-arrests at the metaphase II (MII) stage until fertilization. 
Upon ovulation, fertilization occurs in the oviduct and the mature egg is activated by sperm, 
thereby initiating the resumption of meiosis and the completion of cytoplasmic maturation (1).  
After fertilization, the egg is reprogrammed into a totipotent zygote. The union of paternal and 
maternal haploid genome forms a diploid genome at the pronuclear (1-cell) stage and mitotic cell 
division begins. Following the first three cleavage divisions, the 8-cell embryo undergoes 
compaction, generating a tightly organized cell mass called the morula. Differentiation of the 
morula results in the blastocyst which is composed of a pluripotent inner cell mass and the 
trophectoderm. The late blastocyst will then implant in the uterus.  
 
2. The role of maternal effect genes in egg-embryo transition  
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The quiescence of transcription between meiotic maturation in oocytes and embryonic genome 
activation (EGA) warrants an essential role of accumulated maternal transcripts and proteins 
that are critical for successful preimplantation development  (2) (Fig. 1). The role of maternal 
effect genes in embryo development and axis formation is well known in lower species  (3). 
However, mammalian maternal effect genes have been identified only recently and are a 
developing area of research. EGA occurs when embryonic genes start to be transcribed, though 
the timing of the EGA varies among species. It takes place at the morula stage in sheep and 
rabbits, the 4-8 cell stages in humans and the 2-cell stage in mice. EGA occurs in two phases: 
minor activation at male pronucleus of zygote and major activation at the 2-cell stage in mice  
(4). The functions of EGA are the degradation of oocyte specific transcripts, the replenishment 
of common transcripts by the embryo and gene expression of embryo specific transcripts. Most 
maternal RNA degradation starts upon oocyte maturation and ovulation and by the 2-cell stage 
about 70% are degraded  (5). Though nuclear transcription ceases on oocyte maturation, 
poly(A) tails of existing transcripts are elongated leading to increased translation  (6). 
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Figure 1.1. Overview of mouse oogenesis and egg to embryo transition 
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3. MATER (NLRP5) belongs to NLRP family 
MATER (Maternal Antigen That Embryos Require) was originally identified as an autoantigen 
in the mouse model of autoimmune premature ovarian syndrome  (7). MATER (official symbol: 
NLRP5) is a member of the NLRP gene family, which is a subfamily of CATERPILLAR family. 
The NLRP family is characterized by a pyrin domain (PYD), NACHT, and a leucine-rich repeat 
(LRR) domain (Fig. 2). N-terminal effector domain, PYD, has been found in proteins involved in 
inflammation and apoptosis, however, mouse NLRP5 has five tandem hydrophilic repeats (18 
a.a) that has homology with dentrin matrix protein 1(DMP1) instead of the PYD  (9). The central 
NACHT-NTPase domain containing ATP/GTPase-specific p-loop and Mg2+-binding sites is 
found in proteins associated with innate immunity  (8), and LRR domain is involved in protein-
protein interaction.  
There are 14 NLRPs in human and about 20 homologues in mice. NLRPs are known to have a 
role in apoptosis, inflammatory signaling pathways and reproduction. NLRP 1 and 3 act as the 
central scaffold of inflammasome during cell response to microbial infection. They activate 
caspase-1, which activate Interleukin-1B (IL-1β). NLRP3 is linked to five autoinflammatory 
syndromes as well  (10). Regarding reproductive function of NLRPs, 12 isoforms of NLRPs are 
detected in human oocytes and preimplantation embryos and 7 isoforms in spermatozoa  (11). 
Human NLRP7 is implicated in hydatidiform moles, female reproductive failure and testicular 
seminomas. Human NLRP14 is involved in preimplanatation development and spermatogenic 
failure  (12-15). NLRPs expression levels decrease during maternal aging  (15). It is possible that 
the mechanism of developmental failure of NLRPs could be related to inflammatory caspase 
activation with subsequent overproduction of IL-1β  (16). 
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Figure 1.2. Components of SCMC (Adapted from Li et al. Dev Cell. 2008 Sep;15(3):416-25) 
 
 
Figure 1.3. PADI6 is a putative component of SCMC 
(A) Co-immunoprecipitation experiment of overexpressed PADI6 and FLOPED shows 
interaction of PADI6 with FLOPED in COS-1 cells. (B) SCMC model (Adapted from Li et al. Dev 
Cell. 2008 Sep;15(3):416-25) 
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4. Mater: a maternal effect gene that belongs to Subcortical maternal complex (SCMC) 
MATER is a maternal effect gene product whose expression is restricted to oocytes and 
preimplanation embryos. The localization of MATER in oocytes is controversial in the literature: 
Tong et al. showed cytoplasmic localization, while Ohsugi et al. demonstrated cytocortical 
localization  (17,18). Although the target sequences of antibodies are exactly same and both 
antibodies are made in rabbits, the difference of localization could be due to the method used to 
generate antibodies and the immunostaining techniques.  
Matertm/tm oocytes shows normal folliculogenesis, ovulation and fertilization, yet embryos 
conceived from Matertm/tm oocytes arrest at the 2-cell stage. The Matertm/tm phenotype is 
summarized in Table 1  (19). FILIA (daughter in Latin), another maternal factor, was identified 
as a binding partner of MATER (mother in Latin)  (18). Filia null females show normal 
oogenesis, ovulation and fertilization, however, fertility is reduced due to abnormal chromosome 
stability and aneuploidy during early embryogenesis. FILIA warrants normal spindle assembly 
by regulating aurora kinase A (AURKA) and polo-like kinase 1 (PLK1), and normal spindle 
assembly checkpoint through MAD2  (20). Other maternal factors, Factor located in oocytes 
permitting embryonic development (FLOPED) and Transducin-like enhancer of split 6 (TLE6) 
have also been identified. FLOPED (Moep19) is a 15kD protein, which binds to RNA  (21). 
TLE6, a mammalian homolog of Groucho, acts as a transcriptional corepressor in developmental 
processes  (22). Double knockout mutants of Mater and Floped also showed a 2-cell arrest. 
FLOPED, TLE6, and MATER bind to each other and FILIA binds to MATER independently. 
FILIA, MATER, FLOPED and TLE constitute the SCMC (Fig. 3B). PADI6 was suggested as a 
putative binding partner of FLOPED based on the co-IP screening from Floped+/+ and -/- oocytes, 
and co-immunoprecipitation analysis of overexpressed PADI6-Myc and FLOPED-GFP confirms 
	   8	  
physical interaction of PADI6 and FLOPED suggesting PADI6 as another SCMC component 
(Fig. 3A). All SCMC components and PADI6 expression is excluded from the cell-cell contact 
regions from the 2-cell stage onwards and expression occurs only in the trophectoderm in 
blastocyst stage suggesting a possible role of SCMC in cell lineage establishment. FLOPED, 
TLE6, PADI6 and MATER are target genes of Factor in the germline alpha (FIGLA) based on 
microarray and serial analysis of gene expression (SAGE)  (23). FIGLA is a basic helix-loop-
helix (bHLH) transcription factor, which coordinates the expression of zona pellucida protein 1, 
2, and 3. Females lacking FIGLA cannot form primordial follicles (Fig. 2)  (24). 
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Table 1: Similarity of PADI6 and MATER 
*TRC: transcription requiring complex 
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5. Peptidylarginine deiminase 6 (PADI6): a member of the PADI family. 
PADI6 is one isoform of the PADI family; PADIs are responsible for conversion of 
peptidylarginine into citrulline in a Ca2+ dependent manner  (25,26). Citrulline is a non-coding 
native amino acid that is not integrated into protein upon translation, thus post-translational 
modification by PADIs produce peptidylcitrullines. Citrullination causes the loss of the positive 
charge, thus altering the protein structure, which could consequently facilitate changes in its 
function  (27). There are five isotypes of PADI in mammals. Although one prokaryotic enzyme 
(AAF06719) can citrullinate both peptidylarginine and free L-arginine, it has no evolutionary 
link with mammalian PADIs  (28). The five PADI paralogs share 45-55% amino acid sequence 
identity. The catalytic active site Cys 645 is located in the C-terminus where sequence identity is 
highly conserved among PADIs. PADI6 has about 40% sequence identity to the other PADI 
isoforms. However, PADI6 is unique in that it has an altered active cysteine site and a unique 
insertion site. Also, amino acid substitutions at Ca2+ binding sites raise the possibility that 
activity of PADI6 may not be dependent on Ca2+  (25).  The main targets of PADIs are structural 
proteins. PADI1 is mainly expressed in the epidermis and citrullinates keratin and filaggrin  (29). 
PADI2 is ubiquitously expressed and is abundant in the brain and in muscles. PADI3 is 
expressed in hair follicles and citrullinates tricohyalin  (30). PADI4 is expressed in 
haematological systems and is a nuclear enzyme that citrullinates histones and acts as a 
transcriptional coregulator  (26). PADI6 is exclusively expressed in oocytes and early embryos  
(31). Unlike other PADI members, the enzymatic activity of PADI6 is not clear and is under 
investigation. 
 
6. Structures, components and regulation of CPLs  
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CPLs are unique, abundant structures present in mammalian oocytes. They are observed from 
the primary follicle to the blastocyst stage. The numbers of CPLs increase during oocyte 
maturation and are found to be abundant in preovulatory oocytes  (32). They dynamically 
reorganize after fertilization, at compaction and at blastocyst formation. This reorganization is 
possibly associated with cell lineage determination  (33). There are two types of CPLs; CPLs are 
solid and planar in rats and hamsters, and fibrous in humans, mice, dogs, cows and pigs  (34). 
CPLs are also found in rabbits, sheep and monkey oocytes  (35-37). Mouse CPLs are composed 
of 7-15 parallel 10-11nm filaments which are linked to each other by lateral cross-bridges spaced 
approximately every 25nm to form cylinders (Fig. 4). The surface of the filaments are masked by 
proteins with a mass of ~69kD (p69). The filaments were suggested as cytokeratins, however, 
the exact composition of CPLs remains unknown. Protein kinase M (PKM), the catalytic domain 
of Protein kinase C, was suggested as a regulator of CPLs, in that PKM remodels CPLs by 
binding and phosporylating cytokeratin and p69 upon fertilization.  
 
7. Function of CPLs  
Maternal ribosomes are stored in the eggs of most animals and contribute to translation after 
fertilization  (38) and several lines of evidences proposed that CPLs play a role in storing 
ribosomes in mammalian oocytes. First of all, indirect evidence of the localization of ribosomes 
to CPLs comes from whole mount prepared mouse egg TEM images. CPLs give rise to periodic 
chains of particles with the approximate size of ribosomes. The ribosomes within the CPLs 
(21nm) are smaller and less electron-dense than free ribosomes (22.5nm) possibly due to 
interactions with proteins and an altered configuration  (39). Second, CPLs are both RNase and 
Trypsin sensitive. Corroborating evidence of proteinaceous and RNA containing CPLs comes 
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from several fixation studies  (40). Third, the precursor-product relationship between ribosomes 
and CPLs has been observed, whereas the number of ribosomes diminishes in the cytoplasm 
matrix, CPLs become abundant  (41). Fourth, the actual number of ribosomes observed by TEM 
is ~80% less than theoretical ribosomes, calculated based on the amount rRNA, as CPLs become 
prominent  (42). Lastly, about 75% of oocyte ribosomes can be sedimented at 9000g for 12 
minutes, whereas somatic cell ribosomes can be pelleted after >1 hour centrifugation at 100,000g  
(6). To further develop the hypothesis that CPLs store ribosomes, 9000g sedimentation 
experiment was repeated using ribosomal component S6 antibody in Padi6 WT and null oocytes. 
The idea was that if ribosomes are stored in a large CPL complex, large portions of S6 will 
sediment more rapidly in Padi6 WT oocytes. However, S6 in Padi6 null oocytes should pellet 
less readily. Indeed, majority of S6 partitioned in the supernatant of Padi6 null oocytes as 
opposed to Padi6 WT oocytes  (43). To date, lattice-like ribosome storage sites were described 
in humans, protozoans, chickens and lizards  (44-46).  
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Figure 1.4.  The structure of Cytoplasmic lattices (CPLs) and predominant localization of 
PADI6 to CPLs (Wright et al., Dev.Bio. 2003)  
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8. The phenotype of Padi6 null mice  
PADI6 is expressed from the primordial stage and persists up to the blastocyst stage; most 
mRNA is degraded upon oocyte maturation. PADI6 localizes to the cytoplasm, the cortex and 
mainly to CPLs by IEM (4) (31). Padi6 null males are fertile while Padi6 null females are 
infertile. Although folliculogenesis, ovulation and fertilization seem normal in the Padi6 null 
oocytes, embryos from Padi6 null females are unable to progress beyond the 2-cell stage. 
Interestingly, in Padi6 null oocytes, CPLs do not form indicating that PADI6 is required for CPL 
formation  (47). While global levels of ribosomal subunit protein S6 and 18S rRNA are not 
affected in Padi6 null oocytes, solubility of S6 increases as seen by confocal microscopy and 
oocyte fractionation. Unlike Padi6 null oocytes, the global level of S6 is decreased and the 
cortical localization of S6 is disrupted in Padi6 2-cell embryos leading to defective protein 
synthesis. This altered translation results in defective EGA. The Padi6 null phenotype and 
similarity of MATER and PADI6 is summarized in Table 1  (43). 
 
9. Significance of study 
Infertility affects about 15% of the population of the United States  (48). In spite of increased 
understanding of the causes of infertility, ~10% of female infertility cases remain unidentified  
(49). Assisted Reproductive Technologies (ARTs) have led to increased success of fertilization; 
however despite this increased success, one of the major problems in in vitro fertilization (IVF) 
clinics remains the low rate of successful pregnancy. Genetic defect-related embryo deaths and 
issues with implantation appear to result in the difference between fertilization and pregnancy 
rates (80% versus 30%)  (50). Thus women with a defect in a maternal effect gene, which can 
result in genetic defect-related embryo death, are anticipated to contribute to the unexplained 
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infertility cases discussed above. The term “maternal effect” refers to the phenotype of the 
embryo which is dependent on the genotype of the mother. The characterization of the molecular 
mechanism of maternal effect genes will shed new light on genetic diagnoses and the treatment 
of oocyte-based female infertility. I propose to investigate the molecular mechanisms of 2-cell 
arrest in Matertm/tm embryos. I will use a mouse model to elucidate the role of MATER (46% 
sequence identity with human MATER) in female infertility. The proposed study will contribute 
to understanding genetic defects underlying idiopathic infertility and has the potential to lead to 
the development of infertility therapies. 	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Abstract 
Background: Mater and Padi6 are maternal effect genes that are first expressed during oocyte 
growth and are required for embryonic development beyond the two-cell stage in the mouse. We 
have recently found that PADI6 localizes to, and is required for the formation of, abundant 
fibrillar Triton X-100 (Triton) insoluble structures termed the oocyte cytoplasmic lattices 
(CPLs). Given their similar expression profiles and mutant mouse phenotypes, we have been 
testing the hypothesis that MATER also plays a role in CPL formation and/or function.  
Methodology/Findings: Herein we show that PADI6 and MATER co-localize throughout the 
oocyte cytoplasm following Triton extraction, suggesting that MATER co-localizes with PADI6 
at the CPLs. Additionally, the solubility of PADI6 was dramatically increased in Matertm/tm 
oocytes following Triton extraction, suggesting that MATER is involved in CPL nucleation. This 
prediction is supported by transmission electron microscopic analysis of Mater+/+ and Matertm/tm 
germinal vesicle stage oocytes which illustrated that volume fraction of CPLs was reduced by 
90% in Matertm/tm oocytes compared to Mater+/+ oocytes.  
Conclusions: Taken together, these results suggest that, similar to PADI6, MATER is also 
required for CPL formation. Given that PADI6 and MATER are essential for female fertility, 
these results not only strengthen the hypothesis that the lattices play a critical role in mediating 
events during the oocyte-to-embryo transition but also increase our understanding of the 
molecular nature of the CPLs.  
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Introduction  
A unique feature of mammalian oocytes is that transcription ceases upon oocyte maturation 	  (1) 
and does not resume until embryonic transcription becomes activated in the early embryo 	  (2-­‐5). 
During this period of transcriptional quiescence, the oocyte must rely on maternal factors, 
structures, and organelles that have accumulated in the oocyte during growth to mediate this 
critical period, often called the oocyte-to-embryo transition (OET). In non-mammalian species, 
mutation analysis has identified a large number of factors, called maternal effect genes (MEGs), 
which are synthesized and accumulate in the oocyte and then persist in the early embryo where 
they are required for embryonic development 	  (6,7). Phenotypic analysis of mouse knockout 
models has recently lead to the identification of several mammalian MEGs such as Maternal 
Antigen That Embryos Require (MATER) and Peptidylarginine Deiminase 6 (PADI6), two 
highly-abundant oocyte-restricted proteins that are essential for embryonic development beyond 
the two-cell stage 	  (8,9).  
MATER (gene name, NLRP5) was originally identified as an antigen that is involved in a mouse 
autoimmune oophoritis 	  (10). Recently, MATER (mother in Latin) has been identified as a 
component of the SCMC (subcortical maternal complex) along with other maternal factors 
including FILIA (daughter in Latin), FLOPED, and TLE6 	  (11). Additionally, PADI6 has also 
been putatively identified as a component of the SCMC complex. While FILIA is thought to play 
a role in chromosome stability during embryogenesis 	  (12), the role of MATER remains to be 
elucidated. 
PADI6 was originally cloned from the mouse oocyte proteome due to its abundance in 
metaphase II-arrested oocytes and its oocyte-restricted expression pattern 	  (9). Interestingly, 
PADI6 is localized to, and required for, the formation of an abundant, oocyte- and early embryo-
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restricted structure, the cytoplasmic lattices (CPLs or lattices) 	  (9,13). The lattices are composed 
of 5-7 parallel fibers with each fiber containing a repeating unit of ~20nm 	  (14). The bundled 
fibers are first observed at early stages of oocyte growth (30-40µm) 	  (15) and persist in the early 
embryo until the blastocyst stage 	  (16). CPLs were found to be resistant to Triton-X-100 
(Triton), thus, extraction with this detergent provides a valuable tool for studying CPL associated 
proteins 	  (14,17). While CPLs have been observed by electron microscopy since the 1960s, their 
function remains poorly understood. Based on electron microscopy and biochemical analysis, a 
number of older reports predicted that the lattices may function as yolk granules 	  (18) or as a 
ribosomal storage site 	  (15,19-­‐23), with the latter hypothesis being supported by recent data 
from our lab 	  (24). 
Interestingly, Padi6 and Mater share many similar properties. For example, the expression of 
both maternal genes is regulated by the basic helix-loop-helix transcription factor, FIGLA 
(Factor in the germline alpha) 	  (25) and is restricted to oocytes and early embryos in mouse. 
Microarray analysis 	  (26) along with previous studies 	  (9,27,28) suggest that both transcripts 
appear in the oocyte at the primordial/primary follicle stage and then abruptly disappear around 
meiotic maturation. MATER and PADI6 protein expression roughly parallels that of their 
transcripts in oocytes; however, protein levels persist at high levels throughout preimplantation 
development until the blastocyst stage 	  (9,27). Additionally, analysis of Padi6-/- and Matertm/tm 
(tm: targeted mutation) female mice indicates that the phenotypes of embryos conceived from 
these two mutants are strikingly similar with a developmental arrest occurring at the two-cell 
stage; likely due to abnormal embryonic genome activation (EGA) as demonstrated by reduced 
levels of BrUTP and TRC transcripts in these embryos 	  (8,13,24). 
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Based on these similarities, we hypothesized that, similar to PADI6, MATER may also 
play a role in CPL formation. Here we show that PADI6 and MATER co-localize throughout the 
oocyte cytoplasm following Triton extraction and appear to both be associated with large 
complexes of similar molecular weight. Additionally, the solubility of PADI6 (a CPL marker) is 
greatly increased in Mater hypomorph oocytes, suggesting that lattices are significantly reduced 
in Matertm/tm oocytes. As a more direct confirmation of the requirement of MATER for CPL 
formation, we show by electron microscopy that the volume of CPLs is reduced 9.65-fold in 
germinal vesicle (GV) stage Matertm/tm oocytes. Taken together, these results suggest that 
MATER is required for CPL formation. Studies are currently underway to test the hypothesis 
that MATER’s role in CPL synthesis is due to direct interactions with other CPL-associated 
factors and to further investigate CPL function using the Matertm/tm mouse oocyte model.  
 
Results  
PADI6 and MATER co-localize in oocytes and early embryos and appear to associate with 
high molecular weight complexes.   
The localization of MATER and PADI6 has been reported previously 	  (9,27,28). Given that 
PADI6 primarily localizes to the CPLs 	  (9) and is required for CPL formation 	  (13), we believe 
that PADI6 represents a good marker for the CPLs. Therefore, to begin testing the hypothesis 
that MATER plays a role in CPL function, we first carried out confocal immunofluorescence 
microscopy (CIM) to determine if these two maternal factors co-localize. Oocytes and embryos 
were fixed with paraformaldehyde (PFA), permeabilized and stained with anti-PADI6 and anti-
MATER antibodies. The results showed that MATER and PADI6 appear to strongly co-localize 
in the cortex and, to a lesser degree, in the cytoplasm of GV stage oocytes. Co-localization was 
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also observed at the non-opposed cortex regions of 2-cell and 4-cell stage embryos with less co-
localization being observed throughout the cytoplasm in the early embryos (Fig. 1A). 
Interestingly, in two and four cell embryos, PADI6 staining is more strongly localized to the 
cortex than MATER, which can be seen to penetrate deeper into the cytoplasm. CPLs are Triton 
insoluble structures. Therefore, to more directly test the hypothesis that MATER localizes to the 
CPLs, we next extracted GV oocytes with 0.1% Triton for 10 min and then carried out co-
localization analysis using CIM. Following Triton extraction, the cytoplasmic signal of MATER 
and PADI6 was greatly enhanced throughout the oocyte cytoplasm, thus providing an indirect 
line of evidence that MATER is associated with the CPLs (Fig. 1B). To test if MATER and 
PADI6 co-localize in the extracted oocytes, co-localization analysis was performed with Zeiss 
2007 software and the scatterplot shows the degree of co-localization between MATER and 
PADI6 in the extracted oocytes. Mander’s overlap and Pearson’s correlation coefficients (0.97 
and 0.7, respectively) confirm the high degree of colocalization between MATER and PADI6 
(Fig. 1B). 
 To further strengthen the potential association between MATER and PADI6, we next resolved 
proteins from GV stage outbred CD1 mouse oocyte extracts using fast protein liquid 
chromatography (FPLC) and eluted fractions were analyzed by immunoblot using MATER and 
PADI6 antibodies. Results show that PADI6 and MATER appear to co-elute in three different 
fractions. An initial high molecular weight fraction is seen between 2000kD and 669kD, a 
second fraction is observed between 669 and 220 kD, and a third peak is also seen that is below 
the 200 kD molecular weight marker. Additionally, a fraction of PADI6 also appears to elute 
independent from MATER just below the 200 kD marker. The observation that PADI6 and 
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Figure 2.1. Co-localization of MATER and PADI6 in non-extracted and Triton X-100 
extracted GV oocytes and early embryos               
(A) Confocal microscopic images show non-extracted GV-stage oocytes, 2-cell, and 4-cell 
embryos after fixation, permeabilization and incubation with anti-MATER (green) and anti-
PADI6 (red) antibodies. (B) GV oocytes extracted with 0.1% Triton X-100 and stained with 
MATER (green) and PADI6 (red) antibodies. Merged images highlight MATER and PADI6 co-
localization. Scatter plot indicates a degree of co-localization of MATER and PADI6. Region A 
shows pixels with high MATER (green) intensities, region B shows pixels with high PADI6 
(red) intensities, and region C shows pixels with both high MATER (green) and PADI6 (red) 
intensities. Mander’s overlap coefficient: 0.97, Pearson’s correlation coefficient: 0.7. (C) CD1 
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mouse oocyte lysates were chromatographed by FPLC. Eluted fractions (1ml) were analysed by 
immunoblotting with antibodies to PADI6 and MATER. Densitometry was used to generate a 
graph and the values in fraction 11 were set at a relative intensity of 100%. Elution of each 
protein standard is indicated by arrow.  
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MATER appear to co-elute in high (~1,000 to 2,000) molecular weight fractions supports 
the hypothesis that these two maternal proteins are associated with a supramolecular complex 
(Fig. 1C).  
 
The Triton X-100 solubility of PADI6 is increased in Matertm/tm oocytes.  
The oocyte CPLs cannot be visualized by EM in Padi6 null mouse oocytes 	  (24), suggesting that 
the CPLs do not form in the absence of PADI6 and that proteins which normally associate with 
the CPLs are rendered more soluble in the mutant eggs. This idea is supported by our previous 
finding that the Triton solubility of ribosomal components, such as S6, is greatly enhanced in 
Padi6-null eggs 	  (24). Therefore, we decided to use a similar type of approach in Mater mutant 
oocytes to more directly test the hypothesis that MATER plays a role in CPL formation and 
function. We predicted that if CPLs do not form in Matertm/tm oocytes, then PADI6 (a CPL-
associated protein) should become more soluble following Triton extraction. GV oocytes were 
either not extracted or extracted with 0.1% Triton for 10 minutes and prepared for CIM as 
described above. Results showed that, in non-extracted oocytes, the level and localization of 
PADI6 was similar between Mater+/+ and Matertm/tm oocytes with slightly reduced PADI6 level 
at the cortex in Matertm/tm oocytes. However, PADI6 levels were dramatically reduced in 
Matertm/tm oocytes following Triton extraction (Fig. 2A). In order to better quantitate these 
findings, we carried out western blot analysis of non-extracted and Triton extracted oocytes. In 
line with our confocal findings, immunoblot analysis showed that PADI6 levels were similar 
between wild type and Mater hypomorph oocytes. However, following Triton extraction, 
analysis of the insoluble fraction found that, while levels of β-actin were similar, image 
densitometry quantification revealed that levels of PADI6 were reduced by ~50% in the mutant  
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Figure 2.2. PADI6 Triton X-100 solubility is increased in Matertm/tm GV-stage oocytes.                                  
(A) Confocal analysis shows Mater+/+ and Matertm/tm GV-stage oocytes prior to, and following, 
extraction with 0.1% Triton X-100. Oocytes were incubated with PADI6 antibodies (red). (B) 
Western blotting shows expression of MATER and PADI6 protein in Mater+/+ and Matertm/tm 
GV-stage oocytes prior to, and following, 0.1% Triton X-100 extraction. Isolated oocytes were 
either extracted or not extracted with Triton, and then evaluated by Western blotting using either 
anti-MATER, anti-PADI6, or anti-β actin antibodies.   
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compared to the control wild type oocytes (Fig. 2B). Taken together, these results suggest that 
the lattices do not form (or form to a lesser degree) in the absence of MATER, thus releasing 
PADI6 from the insoluble fraction.    
 
Morphometric electron microscopic analysis reveals that CPL volume is greatly reduced in 
Matertm/tm oocytes.     
In order to directly test the hypothesis that MATER is required for CPL formation, we next 
performed morphometric analysis of the CPLs in Mater+/+ and Matertm/tm oocytes using 
transmission electron microscopy (TEM). GV oocytes were collected from three Mater+/+ and 
three Matertm/tm female mice, fixed, embedded with resin, and ultrathin sections of the blocks 
were placed on a grid. The oocytes were then imaged using TEM and quantitation of the CPLs 
and other organelles was then carried out using the point-counting method 	  (29). Results showed 
that the average volume fraction of CPLs per area was 5.5% for Mater+/+ oocytes and 0.057% for 
Matertm/tm oocytes, thus the volume fraction of CPLs in Matertm/tm oocytes was reduced by 9.56 
fold when compared to Mater+/+ oocytes. Standard error of mean (SEM) of the CPL volume 
fraction for Mater+/+ oocytes was 0.0035 and for Matertm/tm oocytes was 0.0009 (Fig. 3) (Fig. 
4C). This result provides direct support of our hypothesis that MATER is required for CPL 
formation. It is important to note that a residual amount of MATER protein is present in 
Matertm/tm oocytes (See Fig. 2B and Discussion below), thus possibly explaining why some 
lattices are observed in hypomorph oocytes.   
Interestingly, while scoring CPL volume by TEM, we also noticed that there was an 
apparent increase in the volume of lipid droplets in Matertm/tm oocytes when compared to 
Mater+/+ oocytes (Fig. 4A). To quantify this observation, we then carried out morphometric  
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Figure 2.3. EM analysis reveals that the volume fraction of CPLs is reduced in Matertm/tm 
oocytes.                                                            
(A) Representative TEM image (x11,500) of the ultrastructure of Mater+/+ GV oocytes.  A high 
magnification (x26,500) image of the lattice structure is shown in the inset. (B) Representative 
TEM image (x11,500) showing the ultrastructure of Matertm/tm GV oocytes. Arrows in A and B 
indicate CPLs. 
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Figure 2.4. Matertm/tm oocytes display elevated levels of lipid droplets. 
 (A) Low magnification (x1,700) TEM images of Mater+/+ and Matertm/tm GV-stage oocytes. 
Oocytes were prepared for TEM as above. White arrows point to LDs. (B) Confocal images of 
GV-stage live Mater+/+ and Matertm/tm oocytes following Nile red staining. DIC images show 
morphology of LDs in oocytes. Close up images (Right panel) highlight LD aggregates. Arrows 
indicate LDs.  (C) Quantitation of the volume fractions of CPLs, LDs, mitochondria, and ER in 
Mater+/+ and Matertm/tm GV-stage oocytes. Mean ± SEM is indicated. P value is < 0.004 for 
CPLs, <0.04 for LD, > 0.05 for mitochondria, and ER.  
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analysis of the LDs in the wild type and mutant oocytes. Additionally, we also scored 
mitochondrial and ER volume to investigate if the volume of these organelles might be altered in 
the Matertm/tm oocytes. We found that, while the volume fractions of mitochondria and ER were 
similar, the volume of lipid droplets increased approximately 7-fold in Matertm/tm oocytes (Fig. 
4C). The finding that mitochondrial volume fraction did not appear to be affected in Matertm/tm 
oocytes is interesting in light of previous immuno-EM data showing that MATER localizes, in 
part, to mitochondria. Experiments are being carried out to address this observation.  In support 
of our EM findings on the increase in lipid droplet volume fraction in Matertm/tm oocytes, we also 
noticed that the morphology of these oocytes seems distinct from Mater+/+ oocytes in that brown 
aggregates were observed in Matertm/tm oocytes under the dissecting microscope. To test if these 
aggregates were LDs, we stained live Mater+/+ and Matertm/tm oocytes with Nile red and the 
merged images show that the aggregates are, in fact, LDs. (Fig. 4B). Finally, while not 
quantitated, we also noticed that the LDs also tended to form larger clusters in Matertm/tm oocytes. 
Quantitation of the CPLs and organelles is shown in Figure 4C.  
 
Discussion 
In this manuscript, we define a new role for MATER by showing that this maternal effect gene 
product appears to be required for CPL formation. Our EM morphometric analysis of the volume 
of CPLs in wild type and Matertm/tm oocytes provides the most direct support of this conclusion 
with results showing that the volume fraction of CPLs is reduced by ~10-fold in Matertm/tm 
oocytes when compared to wild type oocytes. It is important to note here that the Matertm/tm mice 
used in this study were derived from the same mice that were originally characterized as Mater 
null by Tong et al 	  (8). Subsequently, however, Ohsugi et al 	  (28)  later documented that these 
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mice actually express low levels of MATER protein, and thus termed the mice Matertm/tm or 
hypomorphs. We confirmed that these mice do express low levels of MATER protein and thus 
used the Matertm/tm hypomorph terminology for this report. Interestingly, in our study, the 
observed reduction in CPL volume roughly correlates with the 90% reduction in MATER protein 
in the Matertm/tm oocytes, suggesting that there may be a direct 1:1 stoichiometry between 
MATER and CPLs. In other words, decreasing MATER protein concentrations would result in a 
corresponding decrease in lattice number. Thus, by extrapolation, we predict that lattices would 
be absent from true Mater null oocytes.  
With respect to the role of MATER in lattice formation, while it is possible that MATER 
functions indirectly (as an upstream signaling factor for CPL formation, for example), we predict 
that MATER’s role in lattice formation is direct via associations with other CPL components. 
This prediction is based on our observation that PADI6 (a bona fide CPL component) and 
MATER co-localize with each other throughout the cytoplasm and on Tashiro’s immuno-EM 
finding that MATER localizes to the CPLs 	  (30). Therefore, MATER appears to represent a 
component of the CPL superstructure. Further, the observation that PADI6 solubility is increased 
in Matertm/tm oocytes suggests that MATER plays a direct role in helping to nucleate CPL-
associated proteins into the mature CPL superstructure and that, in the absence of MATER, CPL-
associated proteins are rendered more soluble.  
As noted in the introduction, MATER has also recently been found to be associated with, 
and required for, the formation of another supramolecular complex, termed the SCMC, which 
also contains FILIA, TLE6, and FLOPED. Further investigation into the molecular nature of this 
complex finds that Mater, Filia, and Floped-null mice are essential for development beyond the 
early cleavage stages of development. At the molecular level, FPLC and immunoprecipitation 
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analysis suggests that the SCMC is formed by a direct interaction between FLOPED, MATER 
and TLE6, while FILIA appears to associate with the SCMC via direct interaction with MATER 
alone. At the subcellular level, these proteins appear to co-localize at the oocyte subcortex and 
this localization becomes asymmetrically restricted to apical cytocortex of two-cell embryos. In 
morulae, however, expression of the SCMC proteins is limited to the non-opposed cytocortex of 
outer blastomeres and these proteins are not observed within the inner cells. This restricted 
localization pattern has lead to the hypothesis that the SCMC structure may provide a molecular 
marker of embryonic cell lineages and possibly cell fate determinations 	  (11). While the role of 
the SCMC in early development remains to be elucidated, analysis of Filia-null mice suggests 
that this maternal factor plays an important role in integrating the spatiotemporal localization of 
regulators of euploidy and cell cycle progression during early development 	  (12).  
 Interestingly, a very recent report by another group 	  (30) has further characterized 
Floped-null mouse oocytes by electron microscopy and found that CPLs are also absent from 
these mutant oocytes, thus indicating that this SCMC protein is also required for lattice 
formation. Additionally, they found that, while confocal immunofluorescence (IF) analysis of 
isolated oocytes/embryos suggested that FLOPED localized to the cytocortex as shown 
previously 	  (11), immuno-EM analysis indicated that FLOPED primarily localized at the CPLs 
throughout the cytoplasm. The investigators then predicted that this conflict in FLOPED 
subcellular localization patterns was due to the inability of anti-FLOPED antibodies to penetrate 
the cortex of isolated oocytes/embryos, thus resulting in a strong cortical FLOPED staining 
pattern. They then tested this prediction by staining paraffin embedded cross-sections of oocytes 
and embryos and found that, under these conditions, FLOPED staining was seen throughout the 
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cytoplasm and was not concentrated at the cortex. Taken together, the findings by Tashiro et al. 
indicate that FLOPED primarily localizes to the CPLs and is also required for lattice formation.  
 In this report, we first document the co-localization of MATER and PADI6 at the cortex 
of non-extracted oocytes/embryos, and throughout the cytoplasm of Triton extracted oocytes. We 
predict that the punctate co-localization of PADI6 and MATER throughout the cytoplasm of 
Triton extracted oocytes is reflective of the localization of these maternal factors to the Triton-
resistant CPLs. This prediction is supported by our previous immuno-EM finding showing that 
PADI6 primarily localizes to the CPLs and by the new Tashiro publication 	  (30) which shows 
that, anti-MATER coated gold particles also localize to the CPLs. While we currently do not 
fully understand why PADI6 and MATER confocal IF staining is primarily limited to the cortex 
in non-extracted oocytes, the new findings on FLOPED localization by Tashiro raise the 
possibility that the observed cortical localization of PADI6 and MATER is artifactual in nature. 
In fact, we have found that the ratio of cortical versus cytoplasmic PADI6 and MATER staining 
in intact oocytes can vary depending on the fixation and immunostaining conditions used 	  (27,28). Alternatively, it is also possible that MATER and PADI6 are associated with the SCMC 
at the cortex and with the CPLs throughout the cytoplasm. The hypothesis that PADI6 is 
associated with the SCMC is supported by previous work showing that PADI6 potentially 
associates with FLOPED, a component of the SCMC 	  (11). If this hypothesis is correct, then it is 
possible that the SCMC and CPL complexes are structurally related and may exist as a 
continuum that cannot be resolved by electron microscopy. Thus, PADI6, MATER, and likely 
other proteins could be found to shuttle between the CPLs and the SCMC. Interestingly, our 
FPLC data may provide some support for this prediction. Our analysis shows that PADI6 and 
MATER appear to co-elute in three separate fractions. The initial high molecular weight fraction 
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(~670 to 2,000) is similar in mass to that shown for MATER and other SCMC components in the 
previous report 	  (11). This finding supports the hypothesis that PADI6 is a component of the 
SCMC. In our study, the observed midrange ~200 to 670 kDa co-elution peak raises the 
possibility that MATER and PADI6 may also be associated with a smaller complex that either 
may not be directly associated with a specific structure. We note that the lowest molecular 
weight MATER and PADI6 co-elution peaks are well below the 200 kDa mass marker and 
predict these fractions represent monomeric forms of PADI6 and MATER. While it is currently 
unclear why Li et al did not also observe the midrange and lower MW peaks for MATER in their 
study, a comparison of protocols finds that we utilized different sized columns which may have 
affected protein resolution. Additionally, we also added 0.1% Trition to our oocyte lysis buffer, 
which may have affected protein solubility. It currently remains unclear whether the association 
between PADI6 and MATER is direct or indirect. For this study, we attempted numerous co-
immunoprecipitation experiments and were not able to show an interaction between PADI6 and 
MATER. Interestingly, given that PADI6 was identified as a potential interacting partner with 
FLOPED and that FLOPED directly interacts with MATER, it is possible that PADI6 and 
MATER indirectly associate via interactions with FLOPED.  
 An unexpected finding from this study was that, in addition to the reduction of CPLs in 
Matertm/tm oocytes, the volume of lipid droplets was significantly increased in the mutant oocytes. 
LDs are dynamic organelles that are primarily thought to store energy in the form of neutral 
lipids such as triacylglycerols and sterol esters 	  (31). In spite of the significant progress in LD 
research in recent years, the fundamental mechanisms by which LDs function remain mostly 
unknown. This is particularly true for mammalian oocytes, as there are only a few reports 
suggesting a role for LDs in oocyte function 	  (32-­‐35). Interestingly, LD accumulation is 
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frequently seen in pathologic conditions such as apoptosis, cancer, and inflammation 	  (36). A 
recent report has found an interaction between MATER and PKC {epsilon}, which is involved in 
the anti-apoptotic pathway 	  (36,37). If MATER is indeed associated with an anti-apoptotic 
signaling pathway, LD accumulation in Matertm/tm oocytes may be associated with apoptotic 
events. Importantly, our findings indicate that Matertm/tm mice represent a valuable tool to study 
LD function in oocytes.   
 To conclude, in this study we show that MATER is required for CPL formation and also 
appears to represent a component of the CPL superstructure. In light of the new finding by 
Tashiro that another SCMC component, i.e. FLOPED, is also required for CPL formation, and 
that PADI6 was identified at a putative FLOPED interacting proteins, our new findings now 
highlight a potential relationship between the SCMC and the CPLs. Additionally, given the 
oocyte/embryo-restricted nature of PADI6 and MATER and that these factors are all essential for 
early cleavage divisions, these findings further highlight the importance of the CPLs in 
mediating the oocyte-to-embryo transition. Furthermore, given that MATER and PADI6 are both 
expressed in human oocytes, a better understanding of the role of murine MATER, PADI6, and 
the lattices in early developmental events may provide insight into human infertility.  
 
Materials and Methods  
 
Ethics statement 
Animals were bred and maintained in accordance with Cornell animal care guidelines and animal 
protocol number 2007-0113 was approved by the Cornell Institutional Animal Care and Use 
Committee before implementation.  
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Animals  
The generation and validation of the Matertm/tm mouse strain has been described previously 	  (8). 
CD-1 breeding mice were purchased from commercial vendors.  
 
Collection and culture of oocytes and embryos  
Oocytes were harvested from 4- to 6-week-old Mater+/+ and Matertm/tm mice. GV-stage oocytes 
were harvested 46-48 hours after intraperitoneal injection of 5IU pregnant mare serum 
gonadotrophin (PMSG). 46-48hours post PMSG, 5IU of human chorionic gonadotrophin (hCG) 
was administered intraperitonealy and Metaphase II (MII) oocytes were harvested 12-14 hours 
later. Oocytes were collected in M2 medium (Sigma) and 5 µM milrinone (Sigma) or 200 µM 
IBMX (Sigma) was added to the media when GV oocytes were used. For collection of 
preimplantation embryos, mice were superovulated with PMSG/hCG as above, mated, and two-
cell and four-cell embryos were collected 2 and 3 days later, respectively.   
 
Confocal microscopy  
Immunostaining and Triton extraction procedures for oocytes have been described elsewhere 
(Yurttas et al., 2008). Oocytes and embryos were fixed in 4% paraformaldedyde (PFA) (EM 
Sciences) for 30 minutes. For extraction, oocytes were incubated in extraction buffer containing 
0.1M KCl, 20mM MgCl2, 3mM EGTA, 20 mM HEPES (pH 6.8), 0.1% Triton X-100 and 1x 
Complete Protease Inhibitor Cocktail (Roche) for 10 minutes and rinsed in PBS quickly and 
fixed. Oocytes were permeabilized with 0.5% Triton X-100 in PBS for 30 minutes, washed and 
incubated with rabbit anti-MATER (1:1000) (Tong et al., 2004) or guinea pig anti-PADI6 
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(1:1000) (Wright et al., 2003) in IF buffer (1% BSA, 0.5% Normal Goat Serum in PBS) for 1 
hour followed by another 1h incubation with the appropriate Alexa Fluor-conjugated (1:450) 
secondary antibody (Molecular Probes) in IF buffer. Oocytes were mounted on slides with 
Slowfade Gold antifade agent (Molecular Probes) and imaged using an LSM 510 laser scanning 
confocal microscope (Carl Zeiss). Confocal microscope settings for comparison of MATER 
expression between Mater+/+ and Matertm/tm oocytes were identical. For Nile red staining, oocytes 
were quickly washed 5 times in M2 medium, 3 times in MEM alpha medium (Invitrogen), and 
then incubated with Nile red (Sigma, 5µg/1ml) in MEM alpha medium for 5 minutes. Oocytes 
were briefly washed in PBS/PVA and PBS, attached to MatTek dishes (MatTek Corporation), 
which were then filled with MEM alpha. All procedures were carried out at room temperature.   
 
Gel Filtration Chromatography 
Eighty GV oocytes were collected from ovaries of CD-1 female mice. Using an AKTApurifier 
FPLC System (GE Healthcare), oocyte lysates were chromatographed on a superpose 6 K9/30 
column pre-equilibrated with several column volumes of chromatography buffer containing 
154mM NaCl, 50mM Na phosphate (PH 7.4), 5mM EDTA, and 0.02% NaN3. Elution positions 
of molecular weight standards (Sigma) were used to calibrate the column and determine the void 
volume. Fractions (1.0 ml) were transferred to a PVDF membrane by slot blot manifold (Hoefer 
PR 648) and analyzed by immunoblot. FPLC experiments were repeated two times. The 
immunoblot was scanned and relative intensity of bands was measured by ImageJ.  
 
Western blotting  
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Mater+/+ and Matertm/tm GV oocytes (15 for non-extracted and 25 for extracted), were collected, 
lysed in 4X Laemmli buffer (8% SDS, 40% glycerol, 20% 2-mercaptoethanol, 0.25M Tris HCl 
pH 6.8, 0.008% bromophenol blue), and boiled for 10 minutes at 100°C. Samples were run on a 
10% SDS-PAGE gel at 100-120 V and transferred to PVDF membranes at 250mA for 2 hours. 
Membranes were blocked with 5% milk in 0.1 % TBS-T overnight at 4°C and subsequently 
incubated with PADI6 (1:13,000), MATER (1:12,000), and β-actin (1:1,000, Abcam) antibodies 
for 1-2 hour followed by anti-guinea pig (1:15,000), anti-rabbit (1:15,000) HRP antibody 
(Jackson ImmunoResearch) for 1 hour. Blots were developed using Immobilon Western HRP 
Chemiluminescent Substrate (Millipore). Films were scanned and densitometry was performed 
by Adobe photoshop CS4 program.  
 
Transmission electron microscopy  
Electron microscopy was performed as described elsewhere 	  (24) with the following 
modifications. GV oocytes were collected from age-matched 4-6 week old Mater+/+ and 
Matertm/tm mice (three mice each) and immediately fixed with 2.5% Glutaraldehyde (EM 
Sciences), 4% PFA, 0.1% tannic acid and 0.01M MgCl2 in 0.1M sodium cacodylate buffer (pH 
7.3) at room temperature for 2 hours then overnight at 4°C. The oocytes were post-fixed with 1% 
osmium teroxide in cacodylate buffer for 1 hour, en bloc stained with 2% uranyl acetate, 
dehydrated in a graded ethanol series and then embedded in LX-112 resin (Ladd Research). Thin 
sections (50-70nm) were cut with a diamond knife (Diatome) on an AO/Reichert ultramicrotome 
and picked up on nickel 200 mesh thin bar grids. Grids are contrast stained with 2% uranyl 
acetate followed by Sato’s modified lead stain. Samples were examined by a FEI T12 TWIN 
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transmission electron microscopy (TEM) at 100kV and images were collected with a Gatan 
Orius® dual-scan CCD camera.   
 
Morphometric analysis  
For morphometric analysis, TEM images (x 11,500) were overlayed with a 2106 cross point grid 
(0.8 cm spacing) using ImageJ, and points occupied by CPLs, LDs, mitochondria, and ER were 
scored using the point-counting method 	  (29). The scoring was performed on 18 randomly 
spaced thin sections, with 3 sections from each of 6 different oocytes, which were obtained from 
3 independent biological replicates of both Mater+/+ and Matertm/tm mice. 
 
Statistical analysis  
Means and standard error of the mean (SEM) were calculated for organelle volume fraction of 
Mater+/+ and Matertm/tm oocytes and statistical significance was calculated using a two-tailed t-
test in Microsoft Excel 2007 program. P-value<0.05 was regarded as statistically significant. All 
experiments were repeated at least three times unless written otherwise.  
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CHAPTER III 
THE ROLE OF MATER IN ENDOPLASMIC RETICULUM 
DISTRIBUTION AND CALCIUM HOMEOSTASIS 
 IN MOUSE OOCYTES 
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Abstract  
Ca2+ oscillations are a hallmark of mammalian fertilization and play a central role in the 
activation of development.  The calcium required for these oscillations is primarily derived from 
the endoplasmic reticulum (ER), which accumulates in clusters at the microvillar subcortex 
during oocyte maturation.  The migration of the ER to the cortex during maturation is thought to 
play an important role in rendering the ER competent to generate the calcium transients and this 
redistribution of ER is thought to be primarily mediated by microtubules and microfilaments. We 
have previously shown that the oocyte- and early embryo-restricted maternal effect gene Mater 
(Nlrp5) localizes to, and is required for, formation of the oocyte cytoplasmic lattices, a tubulin 
containing structure that appears to play an important role in organelle positioning and 
distribution during oocyte maturation. Given these observations, we hypothesized that Mater 
may be also be required for ER redistribution and Ca2+ homeostasis in oocytes. To test this 
hypothesis, we first investigated ER localization in metaphase-II Matertm/tm oocytes and found 
that, as opposed to wild type oocytes, ER clusters were not concentrated at the microvillar 
cortex. We next investigated if the pattern of Ca2+ oscillations was altered in Matertm/tm oocytes 
after fertilization in vitro. Intriguingly, the Ca2+ oscillation patterns in Matertm/tm oocytes showed 
a significantly lower amplitude of the first peak and higher frequency when compared to wild 
type oocytes. We then found that the Ca2+ oscillation defect in Matertm/tm oocytes was likely 
caused by a reduced amount of intracellular Ca2+ stores in the ER using ionomycin and 
thapsigargin. Additionally, we found that, while the level of IP3R-I (an essential mediator of ER-
derived Ca2+) in Matertm/tm oocytes was similar to that of Mater+/+ oocytes, the localization of 
IP3R-I was altered in mutant eggs. To investigate the potential mechanisms by which MATER 
mediates ER redistribution, we also tested whether tubulin levels/localization was affected in the 
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mutant oocytes and found that Triton-insoluble fraction of Tubulin was significantly decreased in 
Matertm/tm oocytes.  Taken together, these observations support the hypothesis that MATER is 
required for ER distribution and Ca2+ homeostasis in oocytes, likely due to defects in lattice-
mediated ER positioning and/or redistribution.   
 
Introduction 
Ca2+ oscillations are a hallmark of mammalian fertilization and initiate the transition of oocytes 
into early embryos (1-­‐3). Calcium release is initiated when sperm release phospholipase C zeta 
(PLCζ) into the oocyte cytoplasm (4). PLCζ then cleaves phosphatidylinositol 4, 5-bisphosphate 
(PIP2) into 1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG). Binding of IP3 to IP3 receptors 
(IP3Rs) located at the ER membranes elicits the release of Ca2+ from the ER resulting in a rise of 
intracellular Ca2+ ([Ca2+i]	  (5).  This initial rise in [Ca2+i] is followed by repetitive [Ca2+i] 
transients, termed Ca2+oscillations, which stimulate egg activation and embryonic development (6,7).  While the role of [Ca2+i] transients in the early stages of the activation of development are 
now fairly well described in mammals, the role of Ca2+ oscillation patterns in later stages of 
embryonic development are now only beginning to be understood (8).  
 
Metaphase II (MII) arrested oocytes show a higher level of IP3-induced Ca2+ release at 
fertilization compared to GV stage oocytes (9,10). This finding indicates that changes occur 
during oocyte maturation to promote optimized IP3- induced Ca2+ transients. These changes 
include; upregulation and post-translational modification of IP3Rs, an increase of Ca2+ stores, 
and a redistribution of the endoplasmic reticulum (ER) to the microvillar cortex. More 
specifically, Ca2+ stores in the ER have been shown to increase during maturation and these 
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increases are directly correlated with optimized Ca2+ oscillation patterns at fertilization	  (11,12). 
Additionally, expression levels and phosphorylation of IP3R-1, the primary IP3R isoform in 
mammalian oocytes, increases during maturation and these increases are related to IP3R-1 
sensitivity (13-­‐15).  Such molecular changes are accompanied by a redistribution of the ER from 
a more evenly distributed pattern at the GV stage to more polarized pattern that is concentrated at 
the vegetal cortex in metaphase II-arrested oocytes	  (16,17). Given that the initial fertilization-
induced Ca2+ rise is seen to propagate from this region after sperm-egg fusion, it is generally 
believed that these cortical ER clusters are the primary source of calcium for the oscillation. 
Importantly, the redistrubtion of ER during oocyte maturation is conserved across wide ranges of 
species, suggesting that it is likely fundamental functional calcium oscillations (16,18-­‐22).	  	  	  
Regarding the mechanisms by which the ER redistributes during oocyte maturation, previous 
studies have shown that microtubules (MTs) appear to be essential for this process (16,23,24). 
MTs, along with microfilaments, mediate two major redistributions of the ER during oocyte 
maturation from a dispersed ER pattern at the GV stage, to a congression of ER around the 
nucleus during germinal vesicle breakdown (GVBD), and finally to an accumulation of ~1-2µm 
clusters of ER appearing at the cortex of mature MII-arrested oocytes. However, studies 
investigating the role of the cytoskeleton in ER redistributing remain limited. Given that the 
dynamic redistribution of organelles during oocyte maturation occurs within an exceedingly 
large volume (relative to somatic cells), it stands to reason that the oocyte may have evolved a 
specific structure to help facilitate organelle positioning and distribution. Recent studies suggest 
that the oocyte cytoplasmic lattices may represent just such a structure. The cytoplasmic lattices 
first appear as oocytes start to grow and eventually become a dominant feature of the mature 
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metaphase II-arrested mouse oocyte (25-­‐27). More recently, the maternal effect gene, 
peptidylarginine deiminase 6 (PADI6), was found to localize to the lattices, thus providing 
insight into the molecular nature of this structure (28). PADI6 is an oocyte and early embryo 
abundant maternal effect gene that is required for female fertility (29). Through use of Padi6 
knockout mice, we have found that PADI6 is required for lattice formation and that the lattices 
appear to contain or regulate a stable form of non-spindle associated microtubules (30). Further, 
we also found that targeting of the ER and mitochondria to the oocyte cortex and the peri-spindle 
regions during maturation was defective in Padi6 mutant oocytes, thus suggesting that PADI6 
and the lattices play an important role in microtubule-mediated organelle redistribution.  
 
MATER represents another oocyte and embryo abundant maternal effect gene that is 
essential for female fertility (31). We recently showed that, similar to PADI6, MATER also 
localizes to the oocyte lattices and is required for lattice formation (32). Given our findings with 
PADI6, here we decided to test whether similar organelle redistribution defects may occur in 
mutant Mater oocytes.  Additionally, given the requirement of cortical ER clustering for optimal 
calcium signaling in mature oocytes, we also tested whether Ca2+ homeostasis was defective in 
mutant Mater oocytes. Outcomes from our study indicate that both ER positioning and Ca2+ 
homeostasis do appear to be significantly altered in mutant Mater oocytes. These findings 
provide new insight into the molecular mechanisms driving organelle positioning and function in 
the mammalian oocyte.  
 
Results  
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Our previous findings with PADI6 (30) suggested that organelle positioning defects in Matertm/tm 
oocytes might only become manifest after the onset of oocyte maturation.  To test this 
hypothesis, we first stained fully-grown GV stage Matertm/tm oocytes with ER tracker and imaged 
the oocytes by confocal fluorescence microscopy. Results showed that the ER staining patterns 
appeared similar between Mater+/+ and Matertm/tm oocytes (Fig. 1A). This result suggested that, 
similar to PADI6, ER positioning in immature GV stage oocytes does not require MATER. We 
then investigated ER distribution in mature Matertm/tm MII oocytes using ER tracker. Here, we 
found that, as opposed to GV stage oocytes, ER distribution appeared to be affected by depletion 
of Mater. More specifically, we observed that, while the ER was concentrated in cortical clusters 
at the oocyte microvillar region in wild type oocytes, a non-polarized ER distribution pattern was 
observed in mature Matertm/tm MII oocytes, with a markedly reduced number of cortical ER 
clusters (Fig. 1A).  To further test whether ER localization was affected in mutant Mater oocytes, 
we next microinjected MII oocytes with the dicarbocyanine dye DiI18 (DiI), a fluorescent 
lipophilic dye, and imaged DiI-injected oocytes using confocal microscopy (33). We found that 
the DiI staining in Mater+/+ oocytes was more polarized with cortical clusters of ER being seen 
at the oocyte cortex, which is in line with previous reports (16,33,34). However, in Matertm/tm 
MII oocytes, the ER was distributed in a more non-polarized manner with the number of cortical 
ER clusters being reduced (Fig. 1B). In order to gain insight into the dynamics of ER movements 
in mature Matertm/tm oocytes, we then imaged the DiI-stained oocytes by time-lapse microscopy 
at 10 second intervals for 20 minutes. Results show that that the ER cortical clusters appear to be 
stably localized to the cortex of wild-type oocytes (Fig. 2). However, in the mutant oocytes, ER 
clusters are seen throughout the interior of the oocyte cytoplasm, but they do not appear to be 
targeted to the oocyte cortex. 
	  	   55	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Altered endoplasmic reticulum localization and decreased cortical ER 
clustering in metaphase II-arrested Matertm/tm oocytes   
(A) GV stage and MII stage Mater+/+ and Matertm/tm oocytes were stained with ER tracker and 
imaged using confocal microscopy. (B) DiI was microinjected into mature MII-arrested Mater+/+ 
and Matertm/tm oocytes and the localization of DiI (an ER marker) was documented using 
confocal microscopy. DIC images of microinjected oocytes highlight the DiI-containing oil-drop. 
Arrows highlight the cortical ER clusters in Mater+/+ oocytes, which are markedly reduced in 
Matertm/tm oocytes. Scale bar 10µm  
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Figure 3.2.  Endoplasmic reticulum dynamics in mature metaphase II-arrested Mater+/+ 
and Matertm/tm oocytes.  
MII oocytes were microinjected with the ER marker, DiI, washed in HEPES-CZB, attached to 
Mattek dishes, and subjected to time-lapse imaging. Images (63x objective) were obtained every 
10 sec for 20 minutes using a confocal microscope. Images at specific time points are shown. 
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Figure 3.3.  Dynamics of lipid droplets during maturation Mater+/+ and Matertm/tm oocytes in 
vitro. 
 GV-stage Mater+/+ and Matertm/tm oocytes were matured in M16 media at 37°C and 5% CO2. 
Time-lapse images were obtained every 1min for 13h using wide-field microscopy and images at 
specific time points are shown.  
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Previous studies have shown that microtubules are major drivers of ER redistribution during 
oocyte maturation. We showed previously that PADI6 interacts with tubulin at the oocyte lattices 
and that PADI6 and the lattices appear to play a critical role in ER redistribution during oocyte 
maturation (34). These findings suggest that the lattices play an important role in microtubule-
mediated organelle redistribution during maturation. Therefore, to gain more insight into the 
potential mechanisms behind the observed organelle redistribution failure in Matertm/tm oocytes, 
we tested whether the localization and/or levels of tubulin were altered in Matertm/tm oocytes.  
We first investigated whether MATER co-localized with tubulin in Triton X-100 extracted 
Mater+/+ and Matertm/tm oocytes. GV oocytes were extracted for 10 minutes with 0.1% Triton X-
100, fixed, and stained with anti-tubulin and anti-MATER antibodies.  Confocal imaging of the 
oocytes showed that, similar to PADI6, MATER co-localized with non-MT fraction of tubulin in 
the extracted GV oocytes (Fig. 4A), and that, while the total amount of tubulin was not affected 
by depletion of MATER, the amount of Triton-insoluble tubulin was markedly reduced in 
Matertm/tm GV stage oocytes (Fig. 4C, 4D). These results support the hypothesis that MATER 
plays an important role microtubule dynamics in oocytes.  
 
Targeting of the ER to subcortical clusters during oocyte maturation is thought to play a major 
role in ER-mediated Ca2+ signaling at fertilization. The finding that mature MII-arrested 
Matertm/tm oocytes contain a more diffuse ER distribution pattern lead to the hypothesis that ER 
function, particularly as a Ca2+ source, might be compromised in Matertm/tm oocytes.  Therefore, 
we measured intracellular Ca2+ stores in GV and MII oocytes to determine if Ca2+ storage was 
affected in Matertm/tm oocytes at either of these stages. Oocytes were loaded with the Ca2+ 
binding dye, Fluo-4AM (Fluo-4) and treated with ionomycin (1µM) to release intracellular Ca2+ 
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Fig 3.4.  MATER and tubulin appear to be closely associated with each other in oocytes  
(A) Confocal microscopy imaging of Triton X-100 extracted GV-stage oocytes stained with anti-
MATER (red) and anti-alpha-tubulin antibodies (green). Merge images show that MATER 
appears to co-localizate with tubulin in the non-microtubule (MT) associated fraction of Triton 
extracted oocytes. Tubulin and MATER co-localization is highlighted by the arrow in the 3x 
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zoom image at left. (B) The co-localization between tubulin and DDX6 (red, used here as a 
control) is shown in the right panels. The arrowhead in the 3x zoom image highlights the lack of 
co-localization between DDX6 and tubulin.  Scale bar = 10µm. (C) Confocal microscopy images 
of Mater+/+ and Matertm/tm oocytes following Triton X-100 extraction.  The amount of Triton-
insoluble tubulin (green) is decreased in Matertm/tm oocytes compared to that of Mater+/+ . (D) 
Western blotting indicates that the Triton-insoluble fraction of tubulin is sharply reduced in 
Matertm/tm oocytes compared to wild type oocytes. Total tubulin levels, however do not appear to 
be different between mutant and control oocytes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   61	  
stores. The calcium release was then captured by confocal microscopy using a 488nm argon laser 
and BP 505-550nm filters. The traces of Fluo-4 were then normalized to the background levels, 
and analyzed by imageJ. Results show that GV-stage Matertm/tm oocytes responded to ionomycin 
to a similar degree as Mater+/+ oocytes (Fig. 5A). However, we found that, while treatment of 
wild-type metaphase II-arrested oocytes with ionomycin lead to an ~10-fold increase of the 
Fluo4 cytoplasmic intensity, Fluo4 staining in hypomorph oocytes was only increased by ~ 6-
fold, indicating that depletion of MATER lead to a ~1.7 fold decrease in intracellular Ca2+ stores 
(Fig. 5B). To investigate ER Ca2+ stores in hypomorph oocytes, we treated MII oocytes with 
5µM thapsigargin, which specifically blocks the ER Ca2+-ATPase pump (SERCA) (35). Similar 
to ionomycin treatment, we found that Matertm/tm MII oocytes demonstrated a 30% decrease in 
cytoplasmic calcium in response to thapsigargin treatment compared to wild type oocytes (Fig. 
5C). These results suggest that the observed organelle redistribution defect in Mater hypomorph 
oocytes might correlate with the inability of the ER to store calcium during oocyte maturation.  
 
Several lines of evidence indicate that the IP3R-I is a major receptor for releasing Ca2+ from the 
ER in mammalian oocytes (14,36). Given our finding the ER distribution is defective in mutant 
oocytes and that IP3R-I is primarily thought to localize to the ER, we next investigated the 
localization of IP3R-I in Mater+/+ and tm/tm MII oocytes by confocal microscopy. Oocytes were 
fixed, and stained with IP3R-I specific antibody.  Results show that the localization of IP3R-I is 
diffuse throughout the cytoplasm in Matertm/tm oocytes with significantly reduced levels of IP3R-I 
clusters at the oocyte cortex (Fig. 6A). We then sought to determine the abundance of IP3R-I 
protein in Mater+/+ and tm/tm MII oocytes by immunoblotting. Oocytes were collected, lysed, and 
were subjected for immunoblotting.  The blots were then incubated with the anti-Rbt03 antibody 
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Figure 3.5.  Intracellular Ca2+ stores are decreased in Matertm/tm oocytes 
(A) GV oocytes were loaded with Fluo-4 AM (1µM), treated with ionomycin (arrow indicates 
time of treatment) and imaged at ~1.6 second intervals using 20x objective. Histogram of Fluo-4 
intensity shows that GV-stage Matertm/tm oocytes responded to ionomycin to a similar degree as 
Mater+/+ oocytes. (B) MII-arrested Mater+/+ and Matertm/tm oocytes were treated with ionomycin 
(1µM) as above. Results show that Matertm/tm oocytes responded to ionomycin to a significantly 
lesser degree compared to Mater+/+ oocytes. p<0.05 (C) MII Mater+/+ and Matertm/tm oocytes 
were treated with thapsigargin (5µM) as above. Traces of [Ca2+]i changes in  individual Mater+/+ 
and Matertm/tm oocytes are shown at top. Average of [Ca2+]i changes are shown below. Similar to 
ionomycin treatment, the responses of Matertm/tm oocytes to thapsigargin were markedly 
decreased when compared to Mater+/+ oocytes (p<0.05).  
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to detect IP3R-I, and an anti-actin antibody was employed as a loading control. Result indicates 
that expression level of IP3R-I in Matertm/tm oocytes seems to be equivalent to that of Mater+/+ 
oocytes (Fig. 6B). These findings suggest that, while IP3R-I protein levels are not affected by 
MATER depletion, the localization of IP3R-I does appear to be significantly altered in these 
oocytes, thus providing further mechanistic insight into the observed Ca2+ homeostasis defect in 
mutant oocytes.  
 
Ca2+ oscillations are dependent on intracellular Ca2+ stores and are believed to have a spatio-
temporal relationship with clustering of these stores, mainly ER, at oocyte cortex.  Given the 
observed decrease in ER cortical clusters and intracellular Ca2+ stores in Matertm/tm oocytes, we 
next tested whether Ca2+ oscillation patterns might be altered in Mater hypomorph oocytes 
following fertilization. MII oocytes were treated with acid tyrodes to remove the zona pellucida 
and then loaded with Fluo-4. Next, oocytes were inseminated (~100 sperm per µl) with 
capacitated epididymal sperm and the Fluo-4 signal was captured at 20 second intervals for 1 
hour. In vitro fertilization was confirmed by the visualization of the extruded polar body ~2h 
following fertilization.  The Ca2+ oscillation profiles of Mater+/+ and Matertm/tm oocytes were 
then analyzed using ImageJ and representative Ca2+ oscillations from each group are shown (Fig. 
7A). Then the amplitude of the first peak was averaged and the frequency of Ca2+ oscillations 
were calculated. Results showed that the initial Fluo-4 peak in Matertm/tm oocytes was reduced by 
~46% compared to Mater+/+ oocytes. Additionally, we found that the frequency of subsequent 
Ca2+ oscillations was about 50% higher in Matertm/tm oocytes compared to Mater+/+ oocytes (Fig. 
7B).  These results suggest that depletion of Mater significantly hampered the oocytes ability to 
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generate normal Ca2+ oscillations, with hypomorph oocytes showing a Ca2+ oscillation profile 
that was of lower amplitude and higher frequency.  
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Fig 3.6.  IP3R-I distribution is altered in Matertm/tm oocytes  
(A) MII-arrested Mater+/+ and Matertm/tm oocytes were fixed with 4% paraformaldehyde, 
permeabilized with 0.5% Triton-X 100, and stained with an anti-IP3R-I antibody. Results show 
that the localization of IP3R-I is altered in the Matertm/tm oocytes when compared to wild type 
oocytes. Scale bar: 10µm  (B) Proteins from Mater+/+and Matertm/tm oocytes were resolved by 
SDS-PAGE, and transferred to PVDF membrane.  The membrane was probed with anti-IP3R-I, 
MATER, and actin antibodies. Results show that IP3R-I levels do not appear to be significantly 
reduced in Matertm/tm oocytes when compared to wild type oocytes.  
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Figure 3.7.  Matertm/tm oocytes show an altered Ca2+ oscillation pattern following 
fertilization in vitro.  
Zona-free metaphase II-arrested Mater+/+ and Matertm/tm  oocytes were loaded with Fluo-4 AM, 
fertilized in vitro and Ca2+ oscillations were recorded every 20 second for one hour following 
insemination. Fertilization was confirmed by the presence of second polar body extrusion 2h  
A	  
B
A	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after insemination. Images were analysed by ImageJ and the representative graphs from each 
group are shown in (A). The bar graphs of amplitude and frequency in (B) indicate that 
Matertm/tm oocytes and display a lower amplitude and higher frequency of Ca2+ oscillation 
patterns when compared to Mater+/+ oocytes (p<0.05).   
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Discussion  
Cytoplasmic lattices (CPLs) are mammalian oocyte- and embryo- abundant structures, which 
consist of 5-7 ~25nm parallel fibers with each fiber ranging from 200-1000 nm in length (37). 
We recently documented that PADI6 localizes to the lattices and is required for lattice formation, 
thus providing insight into the molecular composition of this enigmatic structure. Additionally, 
we have also shown that tubulin interacts with PADI6 and co-localizes with PADI6 at the CPLs. 
Further, we also found that the Triton-insoluble fraction of tubulin is significantly reduced in 
Padi6-/- oocytes, thus strengthening the argument that tubulin is also a major component of the 
lattices (34).  We have also recently reported that another maternal effect gene, MATER, co-
localizes with PADI6 and is required for lattice formation (38). In this report, we expand upon 
these findings by showing that, similar to PADI6, MATER also co-localizes with the non-MT 
fraction of tubulin in extracted GV oocytes, and that Triton insoluble fraction of tubulin is 
markedly reduced in Matertm/tm GV oocytes. These findings further strengthen the premise that 
tubulin is a component of lattices. While the precise relationship between microtubules and the 
lattices remains to be resolved, our findings to date suggest that the lattices likely play a direct 
role in microtubule dynamics.  
 
Interestingly, another set of studies has identified MATER as a member of the Subcortical 
maternal complex (SCMC), which also contains FLOPED, TLE6, and FILIA. PADI6 was also 
identified in these studies as a putative SCMC member (39). Recently, FLOPED was found by 
another research group to localize to the lattices and be required for lattice formation	  (40). The 
observation that PADI6, MATER, and FLOPED are putative components of the SCMC and the 
lattices strongly suggests that these two entities are connected in some way. We have found that 
	  	   70	  
the localization of MATER and PADI6 can vary dramatically depending on the 
preparation/fixation methods utilized and that, under more stringent conditions, MATER and 
PADI6 do not appear to be cortically localized and, instead are more evenly distributed 
throughout the cytoplasm (41). Therefore, we predict that the SCMC likely represents a 
component of the lattice superstructure and may function to regulate tubulin dynamics. 
Interestingly, we previously found that levels of acetylated tubulin, a marker for the stable 
microtubules (MT) were significantly decreased in Padi6-/- oocytes, suggesting that the lattices 
might represent the stable or modified form of microtubules. In somatic cells, the ER has been 
shown to move throughout the cytoplasm along tracks of acetylated microtubules (42). 
Therefore, while speculative, it is possible that ER targeting to the cortex during maturation is 
carried out by the direct trafficking of the ER along the lattice superstructure itself.  
 
During oocyte maturation the Ca2+ releasing machinery goes through its own maturation process 
in order to mount an optimal Ca2+ response at fertilization with much of this maturation process 
occurring at the level of the ER (43). In addition to events such as IP3R-I phosphorylation, 
cortical targeting and clustering of the ER is thought to be a key aspect of preparing the ER for 
an optimal Ca2+ response. This prediction is highlighted by the fact that ionomycin and, more 
specifically, thapsigargin treatment induces a much more robust cytosolic Ca2+ peak in mature 
MII-arrested oocytes compared to immature GV-stage oocytes (11). In this study, we found that 
calcium release in ionomycin and thapsigargin treated Matertm/tm GV stage oocytes was similar to 
that of wild type oocytes. However, we found that calcium release was reduced by ~40% in 
mature MII-arrested Matertm/tm oocytes compared to wild type oocytes. These findings support 
the hypothesis that the ability of the ER in Matertm/tm oocytes to sequester and store calcium 
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during oocyte maturation is compromised, likely due to the inappropriate targeting of the ER to 
the cortex. Alternatively, however, given that thapsigargin inhibits SERCA, which is responsible 
for returning Ca2+ into ER, it is possible that SERCA expression levels or activity is 
compromised in Matertm/tm oocytes. The finding that ionomycin mounted a similar response to 
that of thapsigargin in Matertm/tm oocytes, however, further supports the hypothesis that the weak 
calcium peak in hypomorph oocytes was actually due to the inability of these oocytes to store 
Ca2+. 
 
The finding that ionomycin and thapsigargin treatment of mature MII-arrested Matertm/tm oocytes 
resulted in a ~2 fold decrease in cytosolic calcium suggested that fertilization-induced calcium 
oscillations would also be compromised in the mutant Mater oocytes. We tested this hypothesis 
and found that calcium oscillations were, in fact, sub-optimal; with a ~50% decrease in the initial 
calcium peak. Interestingly, in addition to this weak initial peak the frequency of subsequent 
oscillations was found to be increased in the Mater hypomorph oocytes. These findings raise the 
possibility that the relatively weak calcium oscillations observed in Matertm/tm oocytes 
compromises oocyte activation and, thus, subsequent stages of embryonic development.  
 
Regarding which stages might be compromised; we found that, following fertilization, extrusion 
of the second polar body occurred without a noticeable delay in Matertm/tm oocytes indicating that 
exit from meiosis did not appear to be compromised in these oocytes. Previous reports have 
documented that fertilized Matertm/tm oocytes formation apparently normal pronuclei and 
undergo the first mitotic cleavage division and then arrest at the two-cell stage (44). These 
observations suggest that the calcium signals generated by Matertm/tm oocytes are sufficient to 
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allow progression through the initial stages of oocyte activation, i.e. the resumption and 
progression of meiosis, extrusion of the second polar body, and proucleus formation.  
 
However, while less understood calcium signaling is also known to be important for molecular 
changes that occur following fertilization and also for the acquisition of developmental 
competence during preimplanation development. For example, protein expressions in 1- and 2- 
cell embryos rely largely on the translation of stored maternal mRNAs (45).  Interestingly, 
mRNA recruitment in early embryos appears to be coupled with Ca2+ oscillations (8,46) 
suggesting that fertilization-induced calcium oscillations temporally regulate the production of 
molecular factors that orchestrate early development. Previous studies have shown that embryos 
derived from Matertm/tm oocytes show a reduction in de novo expression proteins such as those 
found in the Transcription requiring complex (TRC), a major marker of embryonic genome 
activation, and also display altered protein expression profiles (47)	  (48). Therefore, it is 
tempting to speculate that, while the initial calcium peak(s) in Matertm/tm oocytes were sufficient 
to allow the oocytes to exit from meiosis and form pronuclei, these sub-optimal peaks, coupled 
with the increased frequency of the subsequent peaks, lead to a dis-regulated pattern of protein 
synthesis and an eventual two-cell arrest. 
 
Regarding the role of calcium signaling in developmental competence, previous studies have 
shown that alteration of Ca2 oscillation parameters such as a number, amplitude, or frequency in 
parthenogenetically activated oocytes can result in decreased rates of preimplantation 
development (49,50). Additionally, aged mouse oocytes, which show a reduced rate of 
blastocyst formation following IVF (51), were found to display altered Ca2+ oscillation patterns 
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with lower amplitude and higher frequency, and also contain reduced Ca2+ stores. This pattern 
appears remarkably similar to what we have observed for Matertm/tm oocytes, thus raising the 
possibility that depletion of Mater may promote premature oocyte aging. In support of this 
hypothesis, decreased levels of MATER protein have been documented in aged oocytes(52).	   	  
While our report has focused on the role of MATER in ER positioning and distribution, another 
group has recently investigated the role of MATER in mitochondrial positioning and function. 
This study found that, similar to the ER defect described in our report, Matertm/tm metaphase II-
arrested oocytes also display an altered mitochondrial distribution pattern(53). Also, this group 
showed that mitochondria in and 2-cell embryos were dysfunctional. Given the well documented 
interplay between mitochondria and ER with respect to Ca2+ homeostasis, it is possible that the 
Ca2+ store defect described in our study could be attributed, in part, to the loss of a functional 
interaction between the ER and mitochondria in mutant oocytes. Importantly, this study also 
found that  Matertm/tm oocytes/zygotes appear to be under mitochondrial stress as documented by 
the upregulation of the phosphorylation in oxidative stress marker, p66Shc (54).  Therefore, in 
this study we assessed whether Matertm/tm oocytes are under ER stress by measuring protein 
levels of a canonical marker for ER stress, GRP78 (HSPA5), (55)(Fig.8). Results show that 
there is no discernible effect on GRP78 expression level between Mater+/+ and Matertm/tm MII 
oocytes, implying the defects of Ca2+ homeostasis shown in Matertm/tm MII oocytes are not likely 
due to ER stress.   
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Figure 3.8. Protein level of GRP78 appears to be similar between Mater+/+ and Matertm/tm 
MII oocytes 
MII-stage Mater+/+ and Matertm/tm oocytes (55) were lysed, separated by SDS-PAGE gel, and 
transferred to PVDF membranes. Blots were then incubated with anti-MATER, GRP78, and beta 
actin antibodies.The level of beta actin is used as a loading control.
	  	   75	  
In conclusion, our previous study found that MATER is required for formation of the tubulin-
containing cytoplasmic lattices. Here we show that MATER colocalizes with tubulin in the 
Triton-insoluble cell fraction and that depletion of Mater results in increased tubulin solubility. 
These findings suggest that MATER plays an important role in tubulin dynamics. Additionally, 
we show that MATER is also required for the proper targeting and clustering of the ER at the 
microvillar cortex. While the mechanism behind this defect is currently unclear, the identified 
link between MATER and tubulin suggests that the ER positioning defect in mutant oocytes is 
due to an altered cytoskeleton. Additionally, we also document that MATER appears to be 
required for the proper storage of Ca2+ within the ER in mature MII-arrested oocytes. We 
attribute this defect to the inability of mutant oocytes to redistribute the ER during oocyte 
maturation. We also show that the pattern of fertilization-induced Ca2+ oscillations is defective in 
Matertm/tm MII oocytes; with the mutant eggs showing a suppressed initial calcium peak followed 
by an increased frequency of subsequent peaks. We predict that the observed Ca2+oscillation 
defects in mutant Mater oocytes are most likely due to the depleted Ca2+ stores in the ER.  
Lastly, we hypothesize that the altered Ca2+ oscillation pattern observed in fertilized Matertm/tm 
oocytes likely plays an important role in the subsequent 2-cell developmental arrests and future 
experiments will directly test this hypothesis.
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Materials & Methods 
 
Mice 
Oocytes were collected from Mater+/+ and Mater tm/tm mice. The generation of MATER 
transgenic mice has been described elsewhere (44). CD-1 male mice were purchased from 
commercial vendors. Mouse colonies were housed in the ECRF mouse facility at Cornell 
University’s College of Veterinary Medicine in accordance with Cornell animal care guidelines.  
 
Collection of gametes 
Oocytes. Germinal vesicle stage oocytes were collected from 4-6 week female mice in M2 
media (supplemented with 200µM IBMX) approximately 46-48h after injection of 2.5-5IU 
pregnant mare serum gonadotrophin (PMSG). Metaphase II oocytes were collected 12.5-14h 
after injection of ~5 IU of human chorionic gonadotrophin (hCG) and cumulus cells were 
removed using 0.1% Hyaluronidase. For zona-free oocytes, MII eggs were collected in Tyrode-
HEPES buffer with PVA. To remove the zona pellucida, eggs were briefly treated with acid 
tyrode solution (pH 1.6) and washed 3X in Tyrode-HEPES with PVA. Sperm. For in vitro 
fertilization, sperm were collected into 900µl of HTF media (supplemented with 4mg/ml BSA) 
from the caudal epididymis of retired CD1 breeding males.  To capacitate sperm, 100µl of the 
sample was further diluted in 200µl HTF media and incubated for 2-3hours in 37°C incubator 
with 5% CO2.  
 
Ca2+ imaging 
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For Ca2+ imaging, oocytes were loaded with 1.5µM Fluo-4 AM (molecular probes) and 0.2% 
Pluronic F-127 in Tyrode-HEPES buffer with PVA for 20mins at room temperature. Oocytes 
were washed 3X with Ca2+ free Tyrode-HEPES (containing 1mM EGTA) and attached to poly-l-
lysine coated Mattek dish for imaging. After baseline signals were recorded, thapsigargin (5µM) 
or ionomycin (1µM) was added to the media to detect cytosolic Ca2+ stores. Images were taken 
every 1.573second using an Argon laser-equipped confocal microscope. For imaging Ca2+ 
oscillations, eggs were attached to Mattek dish in 50µl of HTF media (without BSA) under 
mineral oil following brief washes in Tyrode-HEPES and HTF media. 50µl of HTF media (with 
8mg/ml BSA) was then added to the dish and the eggs were inseminated with ~3000 sperm.  
Upon insemination, eggs were imaged for 1h every 20 sec using a Zeiss LSM 510 confocal 
microscope.  
Lentiviral infection 
Flag-tagged Mater was subcloned into a TetO-FUW vector and viral packaging plasmids 
psPAX2 and pMD2.G (plasmids were gifts from Dr. John Schimenti) were co-transfected with 
TetO-FUW-Mater, rtTA into 293T cells. Viral supernatants were collected 48h-72h after 
transfection, and rtTA and TetO-FUW-Mater were pooled together and concentrated. 3x105 Cos-
1 cells were seeded into 6 well plates one day prior to infection and cells were infected for 24h. 
2µg/ml doxycycline was added into viral infected cells and assayed 48-72h later. 
 
Western blotting 
Western blotting procedure was described elsewhere (Kim et al. 2010). Briefly, oocytes were 
collected, lysed in Laemmli buffer, and boiled for 10 minutes at 100°C. For anti-Rbt03 western 
blotting, PVDF membranes were run in 7.5% PAGE gel, transferred overnight, blocked in TBST 
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with 5% milk for 2hr and incubated overnight with anti-Rbt03 antibody at 1:1000.  Blots were 
developed using Immobilion Western HRP Chemiluminescent Substrate (Millipore) and 
Chemidoc MP (Biorad).  
 
Microinjection 
To label the endoplasmic reticulum, a saturated solution of DiI 18 (1,1’-dihexadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate 18)  (Molecular Probes) was prepared in soybean oil 
(Sigma). The DiI solution was loaded into a Femtotips II injection pipette (Eppendorf) with a 
microloader (Eppendorf). Oocytes were pressure-injected with the micropipette and Eppendorf  
TransferMan NK2 manipulator mounted on an inverted microscope (Nikon). MII- oocytes were 
injected immediately after collection in M2. They were then placed in a drop of Hepes buffered 
CZB+IBMX covered with mineral oil during the inejction. A holding pipette (Humagen) was 
used to immobilize the oocytes and the injection pipette was pushed through the zona pellucida 
and plasma membrane. Each oocyte receives ~5pl of DiI solution via Eppendorf CellTram Vario 
microinjector. After injection, oocytes were cultured in CZB+IBMX for 0.5-2 hours followed by 
laser-scanning confocal microscopy analyses (Carl Zeiss). 
 
Confocal microscopy  
Immunostaining and Triton extraction procedures for oocytes have been described previously 
(Kim et al., 2010). For Cos-1 cells, cells were fixed with -20°C methanol for 2 mins, and washed 
in PBS. Cells were then permeabilized in 0.5% Triton X-100 for 10 min, washed, and incubated 
with rabbit anti-MATER (1:500) or anti-alpha Tubulin (1:500, Sigma) in PBS with 1% BSA 
followed by 1hour incubation with appropriate Alexa Fluor conjugated secondary antibodies 
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(1:500). Cells were mounted on slides with Fast Gold antifade agent (Molecular Probes) and 
imaged using a Confocal Microscope (Zeiss). For live staining of oocytes, MII oocytes were 
stained with ER tracker (Molecular Probes) for 25 minutes in MEM-alpha supplemented with 
5% FBS, washed, and imaged.  
 
Statistical analysis 
All experiments are repeated for at least three times. The intensity of Fluo-4 was normalized to 
baselines and calculated using ImageJ. Values are given as mean ±STDEV. Values of amplitude 
and frequency were analysed using student’s t-test. Differences of p<0.05 were defined as 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
	  	   80	  
REFERENCES 
(1) Cuthbertson KS, Cobbold PH. Phorbol ester and sperm activate mouse oocytes by inducing 
sustained oscillations in cell Ca2+. Nature 1985 Aug 8-14;316(6028):541-542. 
(2) Whitaker M. Calcium at fertilization and in early development. Physiol Rev 2006 
Jan;86(1):25-88. 
(3) Stricker SA. Comparative biology of calcium signaling during fertilization and egg activation 
in animals. Dev Biol 1999 Jul 15;211(2):157-176. 
(4) Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM, et al. PLC zeta: a 
sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development 
2002 Aug;129(15):3533-3544. 
(5) Miyazaki S, Yuzaki M, Nakada K, Shirakawa H, Nakanishi S, Nakade S, et al. Block of 
Ca2+ wave and Ca2+ oscillation by antibody to the inositol 1,4,5-trisphosphate receptor in 
fertilized hamster eggs. Science 1992 Jul 10;257(5067):251-255. 
(6) Miyazaki S, Ito M. Calcium signals for egg activation in mammals. J Pharmacol Sci 
2006;100(5):545-552. 
(7) Runft LL, Jaffe LA, Mehlmann LM. Egg activation at fertilization: where it all begins. Dev 
Biol 2002 May 15;245(2):237-254. 
(8) Ducibella T, Schultz RM, Ozil JP. Role of calcium signals in early development. Semin Cell 
Dev Biol 2006 Apr;17(2):324-332. 
(9) Fujiwara T, Nakada K, Shirakawa H, Miyazaki S. Development of inositol trisphosphate-
induced calcium release mechanism during maturation of hamster oocytes. Dev Biol 1993 
Mar;156(1):69-79. 
(10) Mehlmann LM, Kline D. Regulation of intracellular calcium in the mouse egg: calcium 
release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation. Biol 
Reprod 1994 Dec;51(6):1088-1098. 
	  	   81	  
(11) Jones KT, Carroll J, Whittingham DG. Ionomycin, thapsigargin, ryanodine, and sperm 
induced Ca2+ release increase during meiotic maturation of mouse oocytes. J Biol Chem 1995 
Mar 24;270(12):6671-6677. 
(12) Tombes RM, Simerly C, Borisy GG, Schatten G. Meiosis, egg activation, and nuclear 
envelope breakdown are differentially reliant on Ca2+, whereas germinal vesicle breakdown is 
Ca2+ independent in the mouse oocyte. J Cell Biol 1992 May;117(4):799-811. 
(13) Mehlmann LM, Mikoshiba K, Kline D. Redistribution and increase in cortical inositol 1,4,5-
trisphosphate receptors after meiotic maturation of the mouse oocyte. Dev Biol 1996 Dec 
15;180(2):489-498. 
(14) Parrington J, Brind S, De Smedt H, Gangeswaran R, Lai FA, Wojcikiewicz R, et al. 
Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the 
type I isoform is upregulated in oocytes and downregulated after fertilization. Dev Biol 1998 
Nov 15;203(2):451-461. 
(15) Xu Z, Williams CJ, Kopf GS, Schultz RM. Maturation-associated increase in IP3 receptor 
type 1: role in conferring increased IP3 sensitivity and Ca2+ oscillatory behavior in mouse eggs. 
Dev Biol 2003 Feb 15;254(2):163-171. 
(16) FitzHarris G, Marangos P, Carroll J. Changes in endoplasmic reticulum structure during 
mouse oocyte maturation are controlled by the cytoskeleton and cytoplasmic dynein. Dev Biol 
2007 May 1;305(1):133-144. 
(17) Kline D, Mehlmann L, Fox C, Terasaki M. The cortical endoplasmic reticulum (ER) of the 
mouse egg: localization of ER clusters in relation to the generation of repetitive calcium waves. 
Dev Biol 1999 Nov 15;215(2):431-442. 
(18) Stricker SA, Silva R, Smythe T. Calcium and endoplasmic reticulum dynamics during 
oocyte maturation and fertilization in the marine worm Cerebratulus lacteus. Dev Biol 1998 Nov 
15;203(2):305-322. 
(19) Terasaki M, Runft LL, Hand AR. Changes in organization of the endoplasmic reticulum 
during Xenopus oocyte maturation and activation. Mol Biol Cell 2001 Apr;12(4):1103-1116. 
(20) Shiraishi K, Okada A, Shirakawa H, Nakanishi S, Mikoshiba K, Miyazaki S. 
Developmental changes in the distribution of the endoplasmic reticulum and inositol 1,4,5-
trisphosphate receptors and the spatial pattern of Ca2+ release during maturation of hamster 
oocytes. Dev Biol 1995 Aug;170(2):594-606. 
	  	   82	  
(21) Jaffe LA, Terasaki M. Structural changes in the endoplasmic reticulum of starfish oocytes 
during meiotic maturation and fertilization. Dev Biol 1994 Aug;164(2):579-587. 
(22) Mann JS, Lowther KM, Mehlmann LM. Reorganization of the endoplasmic reticulum and 
development of Ca2+ release mechanisms during meiotic maturation of human oocytes. Biol 
Reprod 2010 Oct;83(4):578-583. 
(23) FitzHarris G, Marangos P, Carroll J. Cell cycle-dependent regulation of structure of 
endoplasmic reticulum and inositol 1,4,5-trisphosphate-induced Ca2+ release in mouse oocytes 
and embryos. Mol Biol Cell 2003 Jan;14(1):288-301. 
(24) Mehlmann LM, Terasaki M, Jaffe LA, Kline D. Reorganization of the endoplasmic 
reticulum during meiotic maturation of the mouse oocyte. Dev Biol 1995 Aug;170(2):607-615. 
(25) Garcia RB, Pereyra-Alfonso S, Sotelo JR. Protein-synthesizing machinery in the growing 
oocyte of the cyclic mouse. A quantitative electron microscopic study. Differentiation 
1979;14(1-2):101-106. 
(26) Sternlicht AL, Schultz RM. Biochemical studies of mammalian oogenesis: kinetics of 
accumulation of total and poly(A)-containing RNA during growth of the mouse oocyte. J Exp 
Zool 1981 Feb;215(2):191-200. 
(27) Wassarman PM, Josefowicz WJ. Oocyte development in the mouse: an ultrastructural 
comparison of oocytes isolated at various stages of growth and meiotic competence. J Morphol 
1978 May;156(2):209-235. 
(28) Wright PW, Bolling LC, Calvert ME, Sarmento OF, Berkeley EV, Shea MC, et al. ePAD, 
an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to 
egg cytoplasmic sheets. Dev Biol 2003 Apr 1;256(1):73-88. 
(29) Esposito G, Vitale AM, Leijten FP, Strik AM, Koonen-Reemst AM, Yurttas P, et al. 
Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and 
female fertility. Mol Cell Endocrinol 2007 Jul 15;273(1-2):25-31. 
(30) Kan R, Yurttas P, Kim B, Jin M, Wo L, Lee B, et al. Regulation of mouse oocyte 
microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev Biol 2011 Feb 
15;350(2):311-322. 
	  	   83	  
(31) Tong ZB, Nelson LM, Dean J. Mater encodes a maternal protein in mice with a leucine-rich 
repeat domain homologous to porcine ribonuclease inhibitor. Mamm Genome 2000 
Apr;11(4):281-287. 
(32) Kim B, Kan R, Anguish L, Nelson LM, Coonrod SA. Potential role for MATER in 
cytoplasmic lattice formation in murine oocytes. PLoS One 2010 Sep 7;5(9):e12587. 
(33) Mehlmann LM, Terasaki M, Jaffe LA, Kline D. Reorganization of the endoplasmic 
reticulum during meiotic maturation of the mouse oocyte. Dev Biol 1995 Aug;170(2):607-615. 
(34) Kan R, Yurttas P, Kim B, Jin M, Wo L, Lee B, et al. Regulation of mouse oocyte 
microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev Biol 2011 Feb 
15;350(2):311-322. 
(35) Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor 
promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic 
reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A 1990 Apr;87(7):2466-2470. 
(36) Fissore RA, Longo FJ, Anderson E, Parys JB, Ducibella T. Differential distribution of 
inositol trisphosphate receptor isoforms in mouse oocytes. Biol Reprod 1999 Jan;60(1):49-57. 
(37) Gallicano GI, McGaughey RW, Capco DG. Protein kinase M, the cytosolic counterpart of 
protein kinase C, remodels the internal cytoskeleton of the mammalian egg during activation. 
Dev Biol 1995 Feb;167(2):482-501. 
(38) Kim B, Kan R, Anguish L, Nelson LM, Coonrod SA. Potential role for MATER in 
cytoplasmic lattice formation in murine oocytes. PLoS One 2010 Sep 7;5(9):e12587. 
(39) Li L, Baibakov B, Dean J. A subcortical maternal complex essential for preimplantation 
mouse embryogenesis. Dev Cell 2008 Sep;15(3):416-425. 
(40) Tashiro F, Kanai-Azuma M, Miyazaki S, Kato M, Tanaka T, Toyoda S, et al. Maternal-
effect gene Ces5/Ooep/Moep19/Floped is essential for oocyte cytoplasmic lattice formation and 
embryonic development at the maternal-zygotic stage transition. Genes Cells 2010 
Aug;15(8):813-828. 
(41) Morency E, Anguish L, Coonrod S. Subcellular localization of cytoplasmic lattice-
associated proteins is dependent upon fixation and processing procedures. PLoS One 2011 Feb 
16;6(2):e17226. 
	  	   84	  
(42) Friedman JR, Webster BM, Mastronarde DN, Verhey KJ, Voeltz GK. ER sliding dynamics 
and ER-mitochondrial contacts occur on acetylated microtubules. J Cell Biol 2010 Aug 
9;190(3):363-375. 
(43) Carroll J, Jones KT, Whittingham DG. Ca2+ release and the development of Ca2+ release 
mechanisms during oocyte maturation: a prelude to fertilization. Rev Reprod 1996 Sep;1(3):137-
143. 
(44) Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect 
gene required for early embryonic development in mice. Nat Genet 2000 Nov;26(3):267-268. 
(45) Paynton BV, Rempel R, Bachvarova R. Changes in state of adenylation and time course of 
degradation of maternal mRNAs during oocyte maturation and early embryonic development in 
the mouse. Dev Biol 1988 Oct;129(2):304-314. 
(46) Ozil JP, Markoulaki S, Toth S, Matson S, Banrezes B, Knott JG, et al. Egg activation events 
are regulated by the duration of a sustained [Ca2+]cyt signal in the mouse. Dev Biol 2005 Jun 
1;282(1):39-54. 
(47) Tong ZB, Bondy CA, Zhou J, Nelson LM. A human homologue of mouse Mater, a maternal 
effect gene essential for early embryonic development. Hum Reprod 2002 Apr;17(4):903-911. 
(48) Ohsugi M, Zheng P, Baibakov B, Li L, Dean J. Maternally derived FILIA-MATER 
complex localizes asymmetrically in cleavage-stage mouse embryos. Development 2008 
Jan;135(2):259-269. 
(49) Bos-Mikich A, Whittingham DG, Jones KT. Meiotic and mitotic Ca2+ oscillations affect 
cell composition in resulting blastocysts. Dev Biol 1997 Feb 1;182(1):172-179. 
(50) Vitullo AD, Ozil JP. Repetitive calcium stimuli drive meiotic resumption and pronuclear 
development during mouse oocyte activation. Dev Biol 1992 May;151(1):128-136. 
(51) Takahashi T, Igarashi H, Kawagoe J, Amita M, Hara S, Kurachi H. Poor embryo 
development in mouse oocytes aged in vitro is associated with impaired calcium homeostasis. 
Biol Reprod 2009 Mar;80(3):493-502. 
(52) Sharov AA, Falco G, Piao Y, Poosala S, Becker KG, Zonderman AB, et al. Effects of aging 
and calorie restriction on the global gene expression profiles of mouse testis and ovary. BMC 
Biol 2008 Jun 3;6:24. 
	  	   85	  
(53) Fernandes R, Tsuda C, Perumalsamy AL, Naranian T, Chong J, Acton BM, et al. NLRP5 
mediates mitochondrial function in mouse oocytes and embryos. Biol Reprod 2012 May 
3;86(5):138, 1-10. 
(54) Gertz M, Steegborn C. The Lifespan-regulator p66Shc in mitochondria: redox enzyme or 
redox sensor? Antioxid Redox Signal 2010 Nov 1;13(9):1417-1428. 
(55) Hendershot LM. The ER function BiP is a master regulator of ER function. Mt Sinai J Med 
2004 Oct;71(5):289-297
	  	   86	  
 
 
 
 
 
CHAPTER IV 
SETTING THE STAGE FOR FERTILIZATION: 
TRANSCRIPTOME AND MATERNAL FACTORS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boram Kim, Scott Coonrod  
Submitted to Chapter 14 for the 2nd edition of  “Biology & Pathology of the Oocyte ” 
 
	  	   87	  
Introduction 
 Toward the end of oocyte growth, an oocyte matures so that it can be fertilized by a sperm and 
develop into an early embryo. Oocyte maturation encompasses two main interrelated 
developmental programs, nuclear maturation and cytoplasmic maturation  (1). Nuclear 
maturation involves the progression from prophase I of meiosis to metaphase II and can be 
visualized microscopically as germinal vesicle breakdown (GVBD), spindle formation, 
chromosomal condensation/segregation, and polar body extrusion. Cytoplasmic maturation 
prepares the oocyte for activation and early development and is characterized structurally by the 
dramatic redistribution of endoplasmic reticulum (ER) and mitochondria from a relatively 
diffuse localization in germinal vesicle stage oocytes to a much more polarized distribution 
pattern in mature eggs. The targeting of mitochondria around the spindle apparatus is thought to 
provide energy, in the form of ATP, to drive processes such as chromosome segregation while 
the targeting of the ER to distinct cortical clusters underneath the microvillar cortex is believed 
to be required for the generation of repetitive Ca2+ transients that are necessary for activation of 
development  (2,3). At the molecular level, cytoplasmic maturation involves the accumulation 
and processing of mRNA and proteins that are also required for successful activation and early 
development  (4). Microtubules (MTs) play a central role in orchestrating the events of nuclear 
maturation and are also thought to be important mediators of organelle redistribution during 
cytoplasmic maturation  (5). Once mature, the oocyte is then competent for fertilization. Sperm-
egg interaction is a sequential process whereby sperm first passes through the cumulus cell 
extracellular matrix, binds to and penetrates the zona pellucida, and then binds to and fuses with 
the oocyte plasma membrane (oolemma)  (6). The molecular mechanisms behind each of these 
interactions is now coming to light, thus greatly increasing our understanding of the fertilization 
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process in mammals. Due, in part, to the transcriptional arrest that occurs following meiotic 
maturation and prior to activation of the embryonic genome (EGA), the embryo must rely on 
stores of maternal transcripts and proteins to provide the material necessary to make the oocyte-
to-embryo transition (OET)  (4). These stored factors are encoded by maternal effect genes 
(MEG) which can be defined as genes encoded by the maternal genome that are essential early 
embryogenesis. In light of advanced genomics and proteomics technologies, and with assistance 
from non-mammalian organisms, over the last 10 years or so, there has been considerable 
progress in the identification and functional analysis of the role of MEG in mammalian 
development  (7). This chapter will focus on reviewing several aspects of oocyte and early 
embryo biology during the OET including cytoplasmic maturation, the mechanisms of sperm-
egg binding and fusion, and the role of stored maternal factors in mediating early development. 
Most of the insights into early development that will be highlighted here arose from studies using 
mouse models.   
 
A. Cytoplasmic maturation  
 
(a) Cytoplasmic organelles 
Cytoplasmic maturation is characterized at the organelle level, in part, by the dramatic 
coalescence of ER and mitochondria around the spindle apparatus and microvillar cortex thus 
providing localized pools of calcium and ATP for subsequent activation and early development. 
[We note here that, as opposed to human oocytes where microvilli are more evenly distributed, 
mouse oocytes contain a microvillus free region which overlies the spindle apparatus]. Below, 
we will first discuss what is known about mitochondrial, and then ER redistribution during 
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maturation. We will not discuss the redistribution of other organelles due, in part, to the fact that 
very little is known about their dynamics at this developmental time-point.  
	  
(i) Mitochondria 
Oocytes become uncoupled from cumulus cells following ovulation and must sustain their own 
metabolism through the generation of ATP by mitochondria via oxidative phosphorylation  (8). 
Mitochondria are one of the most abundant organelles in oocytes and embryos must rely 
exclusively upon maternally inherited mitochondria until the peri-implantation stage, at which 
point they begin to make their own mitochondrial stores  (9).  During maturation, mitochondria 
undergo a highly conserved, but poorly understood reorganization process; with initiation of 
mitochondrial redistribution coinciding with, and requiring, the resumption of meiosis. In the 
immature oocyte, mitochondria are more-or-less evenly distributed throughout the cytoplasm 
and, as the oocyte begins to mature, they coalesce around the germinal vesicle nucleus at GVBD 
and then become polarized around the spindle during MII stage  (2,10).  This redistribution event 
seems to be critical for the production of functional mitochondria and also for the oocyte to reach 
its full developmental potential. This prediction is based on findings from a range of species 
which show that a successful mitochondrial redistribution in mature oocytes correlates with 
increased ATP activity and/or with a higher developmental potential  (11-15). Not too 
surprisingly perhaps, an oocyte’s developmental potential is apparently not determined by its 
total amount of ATP, but instead it is determined by where these ATP pools localize within the 
oocyte. In other words, to meet the increasing local ATP demands, toward the end of oocyte 
maturation, subsets of mitochondria at the cortex are thought to become hyperpolarized (ΔΨm). 
Interestingly, localization of these high potential mitochondria at subplasmalemma has been 
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correlated with fertilization competency (16). Importantly, mitochondria can be visualized in 
oocytes using light microscopy  (14), thus the non-polarized mitochondrial phenotype in poor 
quality oocytes may, one day, prove to be an invaluable tool for clinical embryologists to select 
embryos with high developmental potential for implantation. Regarding the mechanisms 
mediating maturation-induced mitochondrial redistribution, a key driver of this process is 
thought to be the fraction of microtubules that are not directly associated with the meiotic spindle 
apparatus  (5,15,17). The methods by which mitochondria are trafficked along MTs in somatic 
cells are well documented and involve MT-motors such as the ATPase, kinesin, and dynein  
(18,19). However, much work remains to be done before similar conclusions can be drawn in 
oocytes. In addition to MTs, microfilaments have also been found to play a role in mitochondrial 
transport in oocytes. Recently, for example, Yu et al, found that mitochondrial redistribution 
closely coincided with changes in mitochondrial ATP synthase activity during maturation. 
Surprisingly, while nocodazole-mediated MT depolymerization was found to inhibit the 
perinuclear accumulation of mitochondria during GVBD, this drug did not affect ATP 
production. However, cytochalasin B (which depolymerizes actin filaments) both suppressed the 
formation of mitochondrial clusters and also suppressed ATP production  (20). These strong 
correlative findings suggest that microfilaments are important for the positioning of functional 
mitochondria in mature eggs and that mitochondrial clustering may be prompted by increasing 
energy demands at specific subcellular locations during oocyte maturation. 
 
(ii) Endoplasmic reticulum  
Mammalian development is initiated when a sperm delivers the oocyte activating factor, PLCζ, 
into the egg cytoplasm at fertilization. PLCζ then cleaves PIP2 to IP3 and IP3 binds to the IP3R-I 
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on the ER which induces the opening of ER Ca2+ channels and subsequent release of Ca2+ into 
the cytosol. The resulting [Ca2+]i oscillations are required for the activation of development, a 
process  which includes; meiotic resumption, cortical granule exocytosis, and the initiation of 
embryonic development  (21). Prior to fertilization, the capacity for IP3-induced Ca2+ release 
increases throughout oocyte maturation, with oocytes finally acquiring the ability to initiate 
fertilization-like oscillations late in maturation  (22). This upregulation of the Ca2+-releasing 
machinery likely depends upon a number of factors including changes in Ca2+ stores, changes in 
Ca2+ homeostasis, IP3R-I functionality, and/or the distribution of ER  (23). Regarding the last 
point, the dramatic redistribution of ER during maturation is seen in a range of vertebrate species 
and the close correlation between ER positioning and functional [Ca2+]i oscillations is well 
documented  (24). For example, a spatiotemporal correlation was found between the release of 
Ca2+ and the appearance of IP3R-rich ER clusters at the cortex in mature MII stage oocytes  
(3,25). These clusters form at the vegetal cortex, which is the initiating site for [Ca2+]i 
oscillations. Thus, the appearance of ER clusters at this site is likely the cause of increased IP3 
sensitivity  (26). As with mitochondria, microtubules and microfilaments appear to be 
responsible for ER redistribution during maturation. Additionally, similar to mitochondria, the 
ER undergoes two major rearrangements during maturation, with the ER first congregating 
around the nucleus prior to GVBD, followed by the targeting of ER to the microvillar cortex in 
the mature egg. Based on inhibitor studies, the targeting of ER to the perinuclear region at 
GVBD appears to require microtubules and the MT motor, dynein, while targeting of ER to the 
cortex in the mature egg appears to primarily be mediated by microfilaments  (27).  
 
(iii) ER-mitochondrial clustering 
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ER and mitochondrial clustering during oocyte maturation is associated with 
developmental potential. Electron microscopic and confocal analysis of oocytes finds that 
mitochondria appear to undergo an ordered clustering during maturation and also come into 
close proximity with ER during this time  (9). In somatic cells, a number of studies have found 
that close physical interactions between ER and mitochondria facilitate organelle crosstalk via 
coordinated signaling events. For example, mitochondrial-derived ATP was found to activate ER 
membrane Ca2+ pumps, which, in turn, propagated Ca2+ signals to mitochondria, thus altering 
their metabolic rate. Additionally, mitochondria can act as a Ca2+ buffer by regulating both local 
Ca2+ concentrations and the rate of Ca2+ signaling events  (28). Based on these (and other) 
observations, it seems likely that a functional interplay exists between ER and mitochondria in 
oocytes and that this relationship modulates both Ca2+ homeostasis and ATP supply  (29,30). 
Additionally, the coordinated crosstalk between these two organelles in oocytes may prove to be 
key determinate of successful developmental outcomes in early embryos  (31).  
 
(b) Molecular inventory  
 
(i) Fate of transcripts  
In light of our extended discussion on organelle redistribution during maturation above, here, we 
will discuss the molecular aspects of cytoplasmic maturation. During their extended growth 
phase, mammalian oocytes increase in size from ~20 to ~80 µm, and, during this time, RNA is 
synthesized and stored at relatively high rates  (32). Toward the end of oocyte growth, the rate of 
transcript synthesis slows and mRNA degradation then commences upon oocyte maturation. 
Degradation of the majority of mRNAs is accomplished during maturation and is almost 
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complete in 2-cell embryos  (33).  The fate of mRNA is often correlated with the length of the 
transcript’s poly(A) tail, with some polyadenylated mRNAs being immediately translated into 
proteins, which may then be stored for later use by the oocyte during or following maturation 
and fertilization. Interestingly, it appears that a good many mammalian MEG products fall into 
this category. For example, proteins encoded by most of the MEGs discussed below, are actually 
first expressed during the early stages of oocyte growth. Additionally, proteomic studies have 
found that the mass and isoelectric point of a number of maternal proteins are altered at this time, 
suggesting that some of these stored proteins are activated during meiotic maturation by post-
translational modifications such as phosphorylation  (34). Transcripts that are not immediately 
translated are often deadenylated and subsequently either degraded during maturation or are 
masked from degradation and then stored in ribonucleo protein particles. These dormant 
transcripts can then be re-adenylated and recruited for translation at later timepoints (35). 
Regulation of these activities is mediated in part, by the transcript’s 5’ and 3’ untranslated 
regions, which can associate with different regulatory factors such as CPEB  (36). Additionally, 
a role for small non-coding RNAs in regulating this activity is now coming to light with, for 
example, siRNAs being found to modulate maternal mRNA degradation  (37).  
 
(ii) Role of PADI6/Cytoplasmic lattices in organelle redistribution  
While the redistribution of organelles during oocyte maturation has been reported in diverse 
arrays of species, the mechanisms by which the cytoskeleton mediates this dynamic event remain 
poorly defined. As noted, most studies in this area treat oocytes with drugs (such as taxol or 
cytochalasin B) that alter microtubule or microfilament dynamics and then observe the effects of 
these drugs on organelle distribution  (20,27). Few studies have actually directly observed the 
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proximate relationship between organelles and the cytoskeleton during maturation, nor have 
many studies investigated the molecular mechanisms involved in tethering organelles to 
microtubules or microfilaments. Given that the dynamic redistribution of organelles during 
oocyte maturation is occurring within an exceedingly large volume (relative to somatic cells), it 
stands to reason that the oocyte and early embryo may have evolved a specific structure to help 
facilitate organelle positioning and distribution. Recent studies suggest that the oocyte 
cytoplasmic lattices may represent just such a structure. The cytoplasmic lattices (also called 
cytoskeletal sheets, plaques, lamellae, and fibrillar arrays) are absent from non-growing oocytes 
but increase in number dramatically throughout oocyte growth, eventually becoming a dominant 
feature of the fully grown mouse oocyte  (38). Electron microscopic analysis of the oocyte 
lattices finds that these structures are composed 5-7 ~20 nm filaments lying side by side with the 
filaments appearing to be held in place by cross-bridges spaced every 23-25 nm  (39). Regarding 
the molecular composition of the lattices, previous studies suggested that the lattices represented 
a storage site for yolk, ribosomes, or possibly intermediate filaments  (40-42). More recently, 
immuno-EM analysis found that that peptidylarginine deiminase 6 (PADI6), a highly-abundant 
oocyte and embryo-restricted maternal protein, localizes to the lattices  (43). Regarding 
expression, PADI6 protein is observed in the oocyte cytoplasm as soon as oocytes enter their 
growth phase and the protein persist in embryos up to the blastocyst stage of development, which 
is similar to that of the lattices. Analysis of Padi6-null oocytes found that lattices are not 
observed in mutant oocytes at any point in oocyte growth or in early embryos, suggesting that 
PADI6 is a component of the lattice complex and that, in the absence of PADI6, the lattices do 
not form  (44).  In addition to PADI6, two other maternal factors, MATER and FLOPED, have 
also been found to localize to, and be required for, lattice formation  (45,46). MATER is a 
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member of the NLRP gene family and contains five tandem hydrophilic repeats at its N-
terminus, a NACHT-NTPase domain within its core region, and a leucine-rich repeat (LRR) 
domain at its C-terminus  (47). The functional significance of these domains within MATER has 
yet to be explored. FLOPED encodes an atypical KH-domain RNA binding domain  (48). The 
expression patterns for both MATER and FLOPED in oocytes and early embryos are similar to 
PADI6  (43,49,50). Regarding a role for the lattices in early development, a recent study has 
found that alpha tubulin interacts with PADI6 at the oocyte lattices and that tubulin solubility is 
greatly increased in PADI6-null oocytes  (17). These and other findings raise the possibility that 
the lattices may play a direct role in microtubule-mediated organelle distribution during oocyte 
maturation. This prediction was supported by the observation that both mitochondria and ER fail 
to undergo maturation-induced redistribution in PADI6-null oocytes. Further, the diffuse 
organelle distribution pattern observed in mature Padi6-null oocytes was not affected by taxol-
mediated microtubule hyperpolymerization, suggesting that loss of Padi6 results in an 
uncoupling of organelles from microtubules. Additionally, levels of acetylated tubulin, a marker 
for stable MT, were strongly suppressed in Padi6-null oocytes, suggesting that the lattices either 
contain, or are associated with stable microtubules  (17). Interestingly, a recent publication 
examined whether mitochondrial distribution or function was altered in mutant Mater oocytes 
during maturation. Indeed, mitochondria were found to be distributed in a non-polarized fashion 
and mitochondrial activity was also disrupted in mutant metaphase II-arrested oocytes  (51). 
Taken together, these findings raise the possibility that the lattices represent a novel form of 
stable microtubules that have evolved within the oocyte cytoplasm to facilitate organelle 
positioning and redistribution in oocytes and possibly early embryos.  
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Figure 4.1. Organelle redistribution during oocyte maturation.   
In the fully grown prophase I-arrested germinal vesicle stage oocyte, the endoplasmic reticulum 
(blue) and mitochondria (orange) are diffusely distributed throughout the cytoplasm while 
cortical granules (red) localize to the subcortex. The germinal vesicle nucleus is shown in grey 
and oocyte lattices are shown as black fibers. In the mature metaphase II-arrested oocyte, the 
endoplasmic reticulum is targeted to clusters opposite to that of the spindle apparatus while 
mitochondria are found to be clustered around the spindle with some hyperpolarized 
mitochondria being found at the subcortex. Microtubule organization centers (MTOCs) are 
shown in green.  
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B. Fertilization: The role of egg proteins in sperm-egg binding and fusion  
Mammalian fertilization occurs in a stepwise fashion and initiates when sperm come into contact 
with, and then penetrate, the oocyte’s vestments; the cumulus mass and the zona pellucida (ZP). 
Sperm then enter the perivitelline space and the sperm’s plasma membrane then binds to, and 
fuses with, the microvillar region of the oocyte’s plasma membrane. Following fusion, in 
addition to releasing PLCζ, sperm also release their highly condensed paternal genome into the 
oocyte cytoplasm whereby the sperm chromatin deconsenses and the male and female pronuclei 
form. These pronuclei then are apposed and the two parental genome’s unite, thus completing the 
fertilization process.  
 
(a) Interaction of sperm with the egg vestment 
The cumulus oocyte complex (COC) consists of the ZP-encased oocyte and the surrounding 
layers of cumulus oophorus cells. Cumulus cells secrete a robust extracelluar matrix and it is this 
matrix that sperm must first traverse to reach the ZP. While cumulus-free oocytes can be 
fertilized in vitro, a number of genetic studies have found that deletion of genes that are involved 
in stabilizing the cumulus cell matrix, such as Ambp, Tnfip6, and Ptx3, can affect COC integrity 
and also suppress female fertility  (52). Therefore, the passage of sperm through the cumulus 
matrix appears to facilitate the fertilization process in vivo. While the precise role that cumulus 
cells play in fertilization remains unclear, several reports suggest that the cumulus matrix may 
promote the acrosome reaction  (52). Following penetration of the cumulus cell matrix, sperm 
then interact with, and pass through, the ZP. In mice, the ZP is comprised of three glycosylated 
proteins, ZP1, ZP2, and ZP3 while human oocytes contain a fourth zona protein, ZP4. Numerous 
older reports indicated that O-glycan carbohydrate moieties on ZP3 appear to function as the 
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primary sperm receptor and also to induce the acrosome reaction  (53). These models also 
suggested that, following the acrosome reaction, the exposed inner acrosomal membrane of 
sperm then binds to ZP2 in a secondary reaction that allows for the penetration of sperm through 
the ZP  (54). This long-standing model may now have to be significantly revised as more recent 
genetic ablation studies in mice suggest that ZP3 is not the primary sperm receptor, but instead 
the receptor appears likely to be ZP2  (55). This finding could potentially simplify the 
mechanism of sperm penetration through the zona, with the new model suggesting that sperm-
zona binding and penetration is mediated by interactions between sperm and the N-terminus of 
ZP2 throughout the zona matrix. Additionally, the model posits that, following fertilization, 
cortical granules exocytose their contents into the pervitelline space and these enzymes then 
cleave ZP2, thus destroying the zona’s sperm receptor, thereby preventing polyspermy. Recently 
the molecular identity of the one of proteolytic factors responsible for ZP2 cleavage has been 
identified as Ovastacin (Astl), an oocyte-specific metalloendoprotease  (56). 
 
(b) Sperm-oolemma interaction 
 
(i) SAS1B  
Having penetrated the zona pellicida, the acrosome reacted sperm enters the perivitelline space 
and then binds to, and fuses with, the oolemma at the microvillar region of the plasma 
membrane. A number of earlier studies suggested that the initial binding events may be mediated 
by interactions between integrins on the oolemmal surface and their cognate ligands, the 
ADAMs (A Disintegrin And Metalloprotease domain), on sperm. However, analysis of knockout 
oocytes which lacked the various integrin subunits thought to mediate gamete binding, found that 
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these molecules do not appear to play a role this process  (57). Recently, a sperm-specific 
acrosomal membrane protein, SLLP1, was found to specifically bind to the oocyte plasma 
membrane and its binding partner on the oolemma was then identified through a panning screen 
as the oocyte microvillar membrane-restricted metalloproteinase, SAS1B (Sperm Acrosomal 
SLLP1 Binding)  (58,59).  In vitro studies then found that SLLP1 and SAS1B directly interact 
and that anti-SAS1B antibodies block fertilization. Lastly, analysis of Sas1b-null mice found that 
these females were subfertile. These new studies provide the first defined pair of molecules (i.e. 
sperm membrane SLLP1 and oolemmal SAS1B) that appear to specifically mediate sperm-
oolemmal binding, but do not appear to play a role in subsequent fusion events.  
 
(ii) Tetraspanins 
In addition SASB1, tetraspanins, and glycosyl-phosphatidylinositol-anchored proteins (GPI-AP) 
on the oolemma have also been found to play important roles in sperm-egg binding and fusion. 
Tetraspanins are known to function as “molecular facilitators” by bringing together and 
stabilizing molecular complexes called tetraspanin webs which form between tetraspanins and 
other transmenbrane proteins and also associate with signaling pathways and cytoskeletal 
elements  (60). The first clues that tetraspanins may play an important role in sperm-oocyte 
membrane binding and fusion, came from a study in the late 1990’s which found that a function 
blocking antibody to the tetraspanin, CD9, strongly suppressed sperm-oocyte binding and fusion 
in a dose-dependent manner  (61). A number of subsequent studies in Cd9 null mice found that, 
despite its nearly ubiquitous expression pattern, the only discernible phenotype in mutant mice, 
was that female mice were severely subfertile and that, while sperm could bind to Cd9 null 
oocytes, fusion was almost completely blocked  (62-64). Results from these mutant mouse 
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studies suggested that CD9 is primarily involved in membrane fusion, however, more recent 
studies have found that CD9 may also play a role in sperm-oocyte binding, thus supporting the 
initial anti-CD9 function-blocking antibody study  (65). In addition to CD9, genetic and 
molecular analysis of another tetraspanin, CD81, have found that this protein also appears to play 
an important role in sperm-egg interaction, however, the defects observed in Cd81 mutant 
oocytes are less severe  (66). It is possible that these tetraspanins are directly involved in 
mediating sperm-oocyte interaction by, for example, functioning as a receptor for a sperm ligand. 
However, complementary sperm ligands for CD9 have yet been identified.  
 
(iii) The potential mechanism by which CD9 regulates sperm-egg interaction 
While CD9’s putative sperm ligand remains unknown, the best candidate ligand for mediating 
sperm-oolemmal interaction on the sperm side is the sperm-specific protein IZUMO1. Analysis 
of Izumo1 mutant mice finds that males are infertile and that, while Izumo1-null sperm can 
penetrate the ZP, they cannot bind or fuse with the oocyte plasma membrane  (57). In an ideal 
world, CD9 would be found to be the receptor for IZUMO1, however, an interaction between 
these two proteins has not been demonstrated and the receptor for IZUMO1 remains to be 
determined. An alternate indirect mechanism by which CD9 could facilitate sperm-oolemma 
interaction, is by regulating the structural landscape of the oolemma in cis. For example, CD9 
may interact with other molecules in the oocyte plasma membrane to form a tetraspanin-enriched 
microdomains that are required for sperm-egg interaction. In support of this prediction, previous 
studies found that pre-incubation of eggs, but not sperm, with the large extracellular loop of 
CD9, which tetraspanin-associated proteins normally bind, hampered gamete fusion  (67). 
Another indirect mechanism by which CD9 may regulate sperm-egg interaction is by mediating 
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the microvilliar architecture. A recent electron microscopy study found that CD9 localizes to 
oocyte microvilli and that the microvillar morphology of Cd9-deficient oocytes is altered in 
length, density, and thickness  (68). Lastly, other studies have found that oocytes appear to 
release CD9-containing exosomes that can bind to sperm and thus facilitate sperm-egg fusion by 
allowing for direct interactions between sperm-localized CD9 and oocyte-localized CD9  (69).  
 
(iv) GPI-anchored proteins 
Glycosyl-phosphatidylinositol-anchored proteins (GPI-APs) on the oolemma have also been 
found to be required for sperm-egg binding and fusion. A role for GPI-AP in sperm-egg 
interaction was identified when investigators found that treatment of mouse oocytes with 
phosphatidylinositol-specific phospholipase C (PI-PLC), an enzyme that cleaves the lipid tether 
in GPI-anchored proteins, significantly diminished the ability of the egg to bind to, and fuse with 
sperm. This effect appeared to be limited to oocytes as PI-PLC-treated sperm could fertilize 
oocytes at a normal rate  (70). This study was supported by another report which asked a similar 
question using a mouse genetic model system. These investigators generated an oocyte-specific 
knockout mouse lacking the Pig-a (Phosphatidylinositol glycan class-A) gene, which encodes 
the enzyme that catalyzes the first steps of GPI-anchor biosynthesis. Results showed that oocytes 
which lacked the Pig-a gene matured normally, yet possessed a significantly reduced ability to 
fuse with sperm  (71). To date the molecular identity of the GPI-anchored protein mediating 
these events remains unknown.   
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Figure 4.2. Molecular “players” involved in sperm-oocyte binding and fusion.  
Sperm SLLP1 has recently been shown to directly interact with oocyte-restricted SAS1B, thus 
defining the first pair of molecules known to mediate sperm-oolemma binding. On the sperm 
side, IZUMO has been shown be required for sperm-oocyte binding and fusion, however its 
cognate receptor on the oolemma is not known. On the oocyte side, GPI-anchored proteins (GPI-
AP) and CD9 have been found to be required for sperm-oocyte binding and fusion, however, 
their putative cognate receptors on sperm have not been identified.  
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C. Maternal effect genes 
In the final section, we will briefly discuss a panel of maternal factors stored within the oocyte 
that facilitate the OET. These genes fit well within the category of maternal effect genes because, 
while their gene products are synthesized by the oocyte, these factors are essential for early 
development. In this summary, we will focus on germ cell-specific maternal effect genes, as it 
seems likely that factors that have evolved specifically to mediate effects in the egg and early 
embryo and are likely to be fundamentally important for early development.   
 
(a) Chromatin remodeling 
 
(i) NPM2 
Maternal and paternal chromatin undergoes remodeling upon fertilization to ensure proper 
formation of the diploid genome. Following entry into the oocyte cytoplasm, decondensation of 
paternal chromatin occurs over a 30 min to 1h time period  (72). In Xenopus, this process is 
thought to be largely mediated by histone chaperones such as nucleoplasmin (NPM) and 
nucleosome assembly protein 1 (NAP1)  (73,74). In mammals, NPM2 protein expression 
initiates in growing oocytes and persist until the blastocyst stage. NPM2 predominantly localizes 
to the nucleus of GV stage oocytes, is dispersed throughout the cytoplasm following GVBD, and 
then translocates back to the nucleus upon pronuclear formation; with nucleocyoplasmic 
shuttling potentially being mediated by phosphorylation  (34). Npm2-null females are subfertile 
with ~60% of embryos arresting around the 2-cell stage of development. In mammals, defects in 
decondensation of the sperm nucleus were not observed in zygotes derived from Npm2–null 
females, thus NPM2 was originally thought not to play a role in sperm nucleus decondensation. 
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However, a recent report found that removal of the nucleolus-like body from GV stage oocytes 
slowed sperm decondensation and that microinjection of NPM2 mRNA partially rescued this 
defect  (75). A potential role for NPM2 in sperm decondensation was further supported by the 
observations that sperm decondensation was retarded in zygotes derived from Npm2-null females 
and that recombinant NPM2 could induce sperm decondensation in vitro. In addition to sperm 
decondensation defects, nuclear and nucleolar abnormalities were detected in null zygotes as 
were defects in histone deacetylation and heterochromatin formation, thus further supporting a 
role for NPM2 as a histone chaperone  (76).  
 
(ii) ZAR1                                                                                                                                                                                  
Zar1 (Zygote arrest 1) is conserved across various vertebrate species including zebrafish, frog, 
mice, and humans. In mice, ZAR1 protein expression initiates in growing oocytes and persist 
until the 2-cell stage of development. Zar1-deficient females are sterile, with embryonic arrest 
occurring at either the pronuclear stage (due to the zygote’s inability to form a diploid genome) 
or at the two-cell stage (due to a suppression of embryonic transcription)  (77). ZAR1 contains 
an atypical plant homeobox domain (PHD) that is found in many transcription factors, thus 
suggesting that this maternal protein may play a role in gene regulation  (78). Additionally, 
ZAR1 was recently found to interact with its homolog ZAR1-like, which colocalizes with 
mRNA processing factors, suggesting that ZAR1 may also regulate RNA metabolism  (79).  
(b) DNA methylation in pre-implantation embryos  
 
(i) DNMT1o 
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 Following fertilization, a small subset of imprinted paternal and maternal genes are spared from 
global DNA demethylation during remodeling of the genome in order to preserve parent-specific 
gene expression patterns in the resulting embryo  (80). An oocyte-specific DNA 
methyltransferase, DNMT1o, has been identified and is now believed to play a critical role in 
maintenance of these methyl marks. Dnmt1o null females are almost entirely infertile, with most 
conceptuses dying between E14-21. Offspring of Dnmt1o deficient females exhibit apparently 
normal global methylation, but display a suppression of methylation at ~50% of allele specific 
imprints  (81). Based on the observation that DNMT1o is targeted to the nucleus of 8-cell stage 
embryos, this methyltransferase is thought to maintain methylation at imprints at that 8-cell 
stage. Interestingly, Hirasawa et al. generated conditional knockouts for both Dnmt1o and 
Dnmt1s genes and found that the resulting embryos showed a complete loss of methylation at 
imprinted loci, indicating that, in addition to DNMT1o, DNMT1s also appears to play an 
important role in maintenance of imprints during preimplantation development  (82).  
  
(ii) STELLA 
 Stella (Dppa3) is expressed in primordial germ cells, oocytes, cleavage stage embryos, and 
pluripotent cells. Analysis of Stella-null female mice found that while oogenesis, ovulation, and 
fertilization appeared normal, these animals were markedly subfertile, due to a developmental 
arrest in preimplantation-stage embryos  (83,84). Stella encodes a protein with a DNA binding-
SAP motif and a splicing factor domain, thus suggesting this factor plays a role in embryonic 
gene transcription and/or mRNA processing. Functional studies indicated that, in collaboration 
with RanBP5, Stella also appears to protect several loci (including imprinted genes) from 
demethylation, thus implicating Stella in maintenance of DNA methylation patterns following 
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fertilization (85). Stella has also been implicated in germ line specification; however, defects of 
this nature were not observed in mutant Stella mice  (83).   
 
(c) Subcortical Maternal Complex  
In addition to PADI6 and MATER’s role in lattice formation and maturation-induced organelle 
redistribution in oocytes, analysis of mutant mice finds these two maternal factors are also 
essential for progression of development beyond the two-cell stage  (44,86). Likewise, FLOPED 
(which is required for lattice formation) is also essential for early development  (50). 
Interestingly, MATER and FLOPED were previously identified as members of a high molecular 
weight complex, named the SubCortical Maternal Complex (SCMC). This complex was also 
found to contain two other maternal genes, FILIA and TLE6, and was also predicted to contain 
PADI6  (50). The precise relationship between the lattices and the SCMC is currently being 
investigated as is the role of the lattices and the SCMC in pre and post-fertilization events. 
Interestingly, in morula stage embryos, members of the SCMC have been found to localize to the 
non-opposed cytocortex of outer blastomeres, while apparently being excluded from the inner 
cells. This restricted localization pattern has led to the hypothesis that the SCMC complex may 
provide a molecular marker of embryonic cell lineages and possibly play a role in cell fate 
decisions during early development  (48,50). 
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Figure 4.3. Potential role for maternal effect genes in early development.  
(A) Nucleoplasmin 2 (NPM2) is targeted to chromatin of decondensing sperm and to male and 
female pronuclei where, as a histone chaperone, it is believed to play a role in chromatin 
remodeling. Zar1 is essential for female fertility, however a role for this maternal factor has yet 
to be defined. (B) Dnmt1o and Stella are both believed to play a role in the maintenance of DNA 
methylation at imprinted loci. (C) The subcortical maternal complex (SCMC) consists of 
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MATER, FLOPED, TLE6, and FILIA, with PADI6 being indicated as a putative component. 
This maternal complex is thought to localize to the non-apposed cytocortex of outer blastomeres 
and excluded from inner cells, thus potentially playing a role in cell fate determination in the 
early embryo.  
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Conclusions and Future Directions 
This chapter has focused on reviewing recent advances in oocyte maturation and fertilization and 
has also discussed the role that stored maternal factors play in mediating the oocyte-to embryo 
transition. Over the last decade, the use of mouse genetic models and “omic” technologies such 
as transcriptomics and proteomics have greatly increased our understanding of how the oocyte 
sets the stage for early development. Perhaps the one of the biggest black boxes that remains to 
be elucidated in this area is how these events are tied together and regulated. In particular, while 
the signaling pathways driving meiotic resumption and completion are fairly well fleshed out, the 
signaling mechanisms that mediate cytoplasmic maturation (structural and molecular) are almost 
completely unknown. A better understanding of these pathways will help us understand how the 
egg prepares for fertilization and activation of development. Likewise, while the mechanisms of 
sperm-oolemmal binding and fusion and oocyte activation are now being elucidated, it seems 
likely that multitude of additional signaling pathways are activated following gamete fusion, thus 
further investigations into these events would likely be productive. For example, while CD9 is 
clearly a critical “player” in sperm-oolemmal binding and fusion, the observation that the 
tetraspanin web is often associated with actin filaments suggests that CD9 may have additional, 
yet to be defined, roles in signaling to the oocyte cytoskeleton. Lastly, the recent use of mouse 
genetic models to investigate the function of a number of oocyte-restricted/abundant gene 
products has led to the finding that many of these molecules are essential for female fertility via 
their role in post-fertilization events. Given that many, if not all, of these genes are conserved in 
humans, a better understanding of these factors and the complexes and structures that they form 
will undoubtedly aid in our understanding of the oocyte to embryo transition and also potentially 
shed light on the mechanisms underlying human fertility and infertility.  
	  	   110	  
REFERENCES 
 (1) Eppig JJ. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. 
Reprod Fertil Dev 1996;8(4):485-489. 
(2) Van Blerkom J, Runner MN. Mitochondrial reorganization during resumption of arrested 
meiosis in the mouse oocyte. Am J Anat 1984 Nov;171(3):335-355. 
(3) Kline D, Mehlmann L, Fox C, Terasaki M. The cortical endoplasmic reticulum (ER) of the 
mouse egg: localization of ER clusters in relation to the generation of repetitive calcium waves. 
Dev Biol 1999 Nov 15;215(2):431-442. 
(4) Schultz RM. Regulation of zygotic gene activation in the mouse. Bioessays 1993 
Aug;15(8):531-538. 
(5) Van Blerkom J. Microtubule mediation of cytoplasmic and nuclear maturation during the 
early stages of resumed meiosis in cultured mouse oocytes. Proc Natl Acad Sci U S A 1991 Jun 
1;88(11):5031-5035. 
(6) Wassarman PM, Jovine L, Litscher ES. A profile of fertilization in mammals. Nat Cell Biol 
2001 Feb;3(2):E59-64. 
(7) Li L, Zheng P, Dean J. Maternal control of early mouse development. Development 2010 
Mar;137(6):859-870. 
(8) Downs SM. The influence of glucose, cumulus cells, and metabolic coupling on ATP levels 
and meiotic control in the isolated mouse oocyte. Dev Biol 1995 Feb;167(2):502-512. 
(9) Dumollard R, Duchen M, Sardet C. Calcium signals and mitochondria at fertilisation. Semin 
Cell Dev Biol 2006 Apr;17(2):314-323. 
(10) Calarco PG. Polarization of mitochondria in the unfertilized mouse oocyte. Dev Genet 
1995;16(1):36-43. 
(11) Nagai S, Mabuchi T, Hirata S, Shoda T, Kasai T, Yokota S, et al. Correlation of abnormal 
mitochondrial distribution in mouse oocytes with reduced developmental competence. Tohoku J 
Exp Med 2006 Oct;210(2):137-144. 
	  	   111	  
(12) Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, Goncalves PB, et al. 
Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after 
in vitro maturation: correlation with morphological criteria and developmental capacity after in 
vitro fertilization and culture. Biol Reprod 2001 Mar;64(3):904-909. 
(13) Torner H, Brussow KP, Alm H, Ratky J, Pohland R, Tuchscherer A, et al. Mitochondrial 
aggregation patterns and activity in porcine oocytes and apoptosis in surrounding cumulus cells 
depends on the stage of pre-ovulatory maturation. Theriogenology 2004 Jun;61(9):1675-1689. 
(14) Wilding M, Dale B, Marino M, di Matteo L, Alviggi C, Pisaturo ML, et al. Mitochondrial 
aggregation patterns and activity in human oocytes and preimplantation embryos. Hum Reprod 
2001 May;16(5):909-917. 
(15) Brevini TA, Vassena R, Francisci C, Gandolfi F. Role of adenosine triphosphate, active 
mitochondria, and microtubules in the acquisition of developmental competence of 
parthenogenetically activated pig oocytes. Biol Reprod 2005 May;72(5):1218-1223. 
(16) Van Blerkom J. Mitochondrial function in the human oocyte and embryo and their role in 
developmental competence. Mitochondrion 2011 Sep;11(5):797-813. 
(17) Kan R, Yurttas P, Kim B, Jin M, Wo L, Lee B, et al. Regulation of mouse oocyte 
microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev Biol 2011 Feb 
15;350(2):311-322. 
(18) Hirokawa N, Noda Y, Okada Y. Kinesin and dynein superfamily proteins in organelle 
transport and cell division. Curr Opin Cell Biol 1998 Feb;10(1):60-73. 
(19) Boldogh IR, Pon LA. Mitochondria on the move. Trends Cell Biol 2007 Oct;17(10):502-
510. 
(20) Yu Y, Dumollard R, Rossbach A, Lai FA, Swann K. Redistribution of mitochondria leads to 
bursts of ATP production during spontaneous mouse oocyte maturation. J Cell Physiol 2010 
Sep;224(3):672-680. 
(21) Lee B, Yoon SY, Fissore RA. Regulation of fertilization-initiated [Ca2+]i oscillations in 
mammalian eggs: a multi-pronged approach. Semin Cell Dev Biol 2006 Apr;17(2):274-284. 
	  	   112	  
(22) Mehlmann LM, Kline D. Regulation of intracellular calcium in the mouse egg: calcium 
release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation. Biol 
Reprod 1994 Dec;51(6):1088-1098. 
(23) Ajduk A, Malagocki A, Maleszewski M. Cytoplasmic maturation of mammalian oocytes: 
development of a mechanism responsible for sperm-induced Ca2+ oscillations. Reprod Biol 
2008 Mar;8(1):3-22. 
(24) Kline D. Attributes and dynamics of the endoplasmic reticulum in mammalian eggs. Curr 
Top Dev Biol 2000;50:125-154. 
(25) FitzHarris G, Marangos P, Carroll J. Cell cycle-dependent regulation of structure of 
endoplasmic reticulum and inositol 1,4,5-trisphosphate-induced Ca2+ release in mouse oocytes 
and embryos. Mol Biol Cell 2003 Jan;14(1):288-301. 
(26) Dumollard R, Carroll J, Dupont G, Sardet C. Calcium wave pacemakers in eggs. J Cell Sci 
2002 Sep 15;115(Pt 18):3557-3564. 
(27) FitzHarris G, Marangos P, Carroll J. Changes in endoplasmic reticulum structure during 
mouse oocyte maturation are controlled by the cytoskeleton and cytoplasmic dynein. Dev Biol 
2007 May 1;305(1):133-144. 
(28) Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000 
Nov 15;529 Pt 1:57-68. 
(29) Dumollard R, Marangos P, Fitzharris G, Swann K, Duchen M, Carroll J. Sperm-triggered 
[Ca2+] oscillations and Ca2+ homeostasis in the mouse egg have an absolute requirement for 
mitochondrial ATP production. Development 2004 Jul;131(13):3057-3067. 
(30) Campbell K, Swann K. Ca2+ oscillations stimulate an ATP increase during fertilization of 
mouse eggs. Dev Biol 2006 Oct 1;298(1):225-233. 
(31) Liu L, Hammar K, Smith PJ, Inoue S, Keefe DL. Mitochondrial modulation of calcium 
signaling at the initiation of development. Cell Calcium 2001 Dec;30(6):423-433. 
(32) Bachvarova R. Gene expression during oogenesis and oocyte development in mammals. 
Dev Biol (N Y 1985) 1985;1:453-524. 
	  	   113	  
(33) Paynton BV, Rempel R, Bachvarova R. Changes in state of adenylation and time course of 
degradation of maternal mRNAs during oocyte maturation and early embryonic development in 
the mouse. Dev Biol 1988 Oct;129(2):304-314. 
(34) Vitale AM, Calvert ME, Mallavarapu M, Yurttas P, Perlin J, Herr J, et al. Proteomic 
profiling of murine oocyte maturation. Mol Reprod Dev 2007 May;74(5):608-616. 
(35) Eichenlaub-Ritter U, Peschke M. Expression in in-vivo and in-vitro growing and maturing 
oocytes: focus on regulation of expression at the translational level. Hum Reprod Update 2002 
Jan-Feb;8(1):21-41. 
(36) Racki WJ, Richter JD. CPEB controls oocyte growth and follicle development in the mouse. 
Development 2006 Nov;133(22):4527-4537. 
(37) Suh N, Baehner L, Moltzahn F, Melton C, Shenoy A, Chen J, et al. MicroRNA function is 
globally suppressed in mouse oocytes and early embryos. Curr Biol 2010 Feb 9;20(3):271-277. 
(38) Zamboni L. Ultrastructure of mammalian oocytes and ova. Biol Reprod Suppl 1970;2:44-
63. 
(39) Capco DG, Gallicano GI, McGaughey RW, Downing KH, Larabell CA. Cytoskeletal sheets 
of mammalian eggs and embryos: a lattice-like network of intermediate filaments. Cell Motil 
Cytoskeleton 1993;24(2):85-99. 
(40) Bachvarova R, De Leon V, Spiegelman I. Mouse egg ribosomes: evidence for storage in 
lattices. J Embryol Exp Morphol 1981 Apr;62:153-164. 
(41) Weakley BS. Initial stages in the formation of cytoplasmic lamellae in the hamster oocyte 
and the identification of associated electron-dense particles. Z Zellforsch Mikrosk Anat 
1969;97(3):438-448. 
(42) Yurttas P, Vitale AM, Fitzhenry RJ, Cohen-Gould L, Wu W, Gossen JA, et al. Role for 
PADI6 and the cytoplasmic lattices in ribosomal storage in oocytes and translational control in 
the early mouse embryo. Development 2008 Aug;135(15):2627-2636. 
(43) Wright PW, Bolling LC, Calvert ME, Sarmento OF, Berkeley EV, Shea MC, et al. ePAD, 
an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to 
egg cytoplasmic sheets. Dev Biol 2003 Apr 1;256(1):73-88. 
	  	   114	  
(44) Esposito G, Vitale AM, Leijten FP, Strik AM, Koonen-Reemst AM, Yurttas P, et al. 
Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and 
female fertility. Mol Cell Endocrinol 2007 Jul 15;273(1-2):25-31. 
(45) Kim B, Kan R, Anguish L, Nelson LM, Coonrod SA. Potential role for MATER in 
cytoplasmic lattice formation in murine oocytes. PLoS One 2010 Sep 7;5(9):e12587. 
(46) Tashiro F, Kanai-Azuma M, Miyazaki S, Kato M, Tanaka T, Toyoda S, et al. Maternal-
effect gene Ces5/Ooep/Moep19/Floped is essential for oocyte cytoplasmic lattice formation and 
embryonic development at the maternal-zygotic stage transition. Genes Cells 2010 
Aug;15(8):813-828. 
(47) Tong ZB, Nelson LM, Dean J. Mater encodes a maternal protein in mice with a leucine-rich 
repeat domain homologous to porcine ribonuclease inhibitor. Mamm Genome 2000 
Apr;11(4):281-287. 
(48) Herr JC, Chertihin O, Digilio L, Jha KN, Vemuganti S, Flickinger CJ. Distribution of RNA 
binding protein MOEP19 in the oocyte cortex and early embryo indicates pre-patterning related 
to blastomere polarity and trophectoderm specification. Dev Biol 2008 Feb 15;314(2):300-316. 
(49) Tong ZB, Gold L, De Pol A, Vanevski K, Dorward H, Sena P, et al. Developmental 
expression and subcellular localization of mouse MATER, an oocyte-specific protein essential 
for early development. Endocrinology 2004 Mar;145(3):1427-1434. 
(50) Li L, Baibakov B, Dean J. A subcortical maternal complex essential for preimplantation 
mouse embryogenesis. Dev Cell 2008 Sep;15(3):416-425. 
(51) Fernandes R, Tsuda C, Perumalsamy AL, Naranian T, Chong J, Acton BM, et al. NLRP5 
mediates mitochondrial function in mouse oocytes and embryos. Biol Reprod 2012 May 
3;86(5):138, 1-10. 
(52) Ikawa M, Inoue N, Benham AM, Okabe M. Fertilization: a sperm's journey to and 
interaction with the oocyte. J Clin Invest 2010 Apr;120(4):984-994. 
(53) Wassarman PM. Mammalian fertilization: molecular aspects of gamete adhesion, 
exocytosis, and fusion. Cell 1999 Jan 22;96(2):175-183. 
	  	   115	  
(54) Bleil JD, Greve JM, Wassarman PM. Identification of a secondary sperm receptor in the 
mouse egg zona pellucida: role in maintenance of binding of acrosome-reacted sperm to eggs. 
Dev Biol 1988 Aug;128(2):376-385. 
(55) Gahlay G, Gauthier L, Baibakov B, Epifano O, Dean J. Gamete recognition in mice depends 
on the cleavage status of an egg's zona pellucida protein. Science 2010 Jul 9;329(5988):216-219. 
(56) Burkart AD, Xiong B, Baibakov B, Jimenez-Movilla M, Dean J. Ovastacin, a cortical 
granule protease, cleaves ZP2 in the zona pellucida to prevent polyspermy. J Cell Biol 2012 Apr 
2;197(1):37-44. 
(57) Inoue N, Ikawa M, Okabe M. The mechanism of sperm-egg interaction and the involvement 
of IZUMO1 in fusion. Asian J Androl 2011 Jan;13(1):81-87. 
(58) Herrero MB, Mandal A, Digilio LC, Coonrod SA, Maier B, Herr JC. Mouse SLLP1, a 
sperm lysozyme-like protein involved in sperm-egg binding and fertilization. Dev Biol 2005 Aug 
1;284(1):126-142. 
(59) Sachdev M, Mandal A, Mulders S, Digilio LC, Panneerdoss S, Suryavathi V, et al. Oocyte 
specific oolemmal SAS1B involved in sperm binding through intra-acrosomal SLLP1 during 
fertilization. Dev Biol 2012 Mar 1;363(1):40-51. 
(60) Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci 2001 Aug;58(9):1189-1205. 
(61) Chen MS, Tung KS, Coonrod SA, Takahashi Y, Bigler D, Chang A, et al. Role of the 
integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin 
alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A 1999 Oct 
12;96(21):11830-11835. 
(62) Kaji K, Oda S, Shikano T, Ohnuki T, Uematsu Y, Sakagami J, et al. The gamete fusion 
process is defective in eggs of Cd9-deficient mice. Nat Genet 2000 Mar;24(3):279-282. 
(63) Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, et al. Requirement of 
CD9 on the egg plasma membrane for fertilization. Science 2000 Jan 14;287(5451):321-324. 
(64) Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C. Severely reduced female 
fertility in CD9-deficient mice. Science 2000 Jan 14;287(5451):319-321. 
	  	   116	  
(65) Jegou A, Ziyyat A, Barraud-Lange V, Perez E, Wolf JP, Pincet F, et al. CD9 tetraspanin 
generates fusion competent sites on the egg membrane for mammalian fertilization. Proc Natl 
Acad Sci U S A 2011 Jul 5;108(27):10946-10951. 
(66) Rubinstein E, Ziyyat A, Prenant M, Wrobel E, Wolf JP, Levy S, et al. Reduced fertility of 
female mice lacking CD81. Dev Biol 2006 Feb 15;290(2):351-358. 
(67) Zhu GZ, Miller BJ, Boucheix C, Rubinstein E, Liu CC, Hynes RO, et al. Residues SFQ 
(173-175) in the large extracellular loop of CD9 are required for gamete fusion. Development 
2002 Apr;129(8):1995-2002. 
(68) Runge KE, Evans JE, He ZY, Gupta S, McDonald KL, Stahlberg H, et al. Oocyte CD9 is 
enriched on the microvillar membrane and required for normal microvillar shape and 
distribution. Dev Biol 2007 Apr 1;304(1):317-325. 
(69) Miyado K, Yoshida K, Yamagata K, Sakakibara K, Okabe M, Wang X, et al. The fusing 
ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice. Proc Natl 
Acad Sci U S A 2008 Sep 2;105(35):12921-12926. 
(70) Coonrod SA, Naaby-Hansen S, Shetty J, Shibahara H, Chen M, White JM, et al. Treatment 
of mouse oocytes with PI-PLC releases 70-kDa (pI 5) and 35- to 45-kDa (pI 5.5) protein clusters 
from the egg surface and inhibits sperm-oolemma binding and fusion. Dev Biol 1999 Mar 
15;207(2):334-349. 
(71) Alfieri JA, Martin AD, Takeda J, Kondoh G, Myles DG, Primakoff P. Infertility in female 
mice with an oocyte-specific knockout of GPI-anchored proteins. J Cell Sci 2003 Jun 1;116(Pt 
11):2149-2155. 
(72) Perreault SD, Barbee RR, Elstein KH, Zucker RM, Keefer CL. Interspecies differences in 
the stability of mammalian sperm nuclei assessed in vivo by sperm microinjection and in vitro by 
flow cytometry. Biol Reprod 1988 Aug;39(1):157-167. 
(73) Shintomi K, Iwabuchi M, Saeki H, Ura K, Kishimoto T, Ohsumi K. Nucleosome assembly 
protein-1 is a linker histone chaperone in Xenopus eggs. Proc Natl Acad Sci U S A 2005 Jun 
7;102(23):8210-8215. 
(74) Philpott A, Leno GH, Laskey RA. Sperm decondensation in Xenopus egg cytoplasm is 
mediated by nucleoplasmin. Cell 1991 May 17;65(4):569-578. 
	  	   117	  
(75) Inoue A, Ogushi S, Saitou M, Suzuki MG, Aoki F. Involvement of mouse nucleoplasmin 2 
in the decondensation of sperm chromatin after fertilization. Biol Reprod 2011 Jul;85(1):70-77. 
(76) Burns KH, Viveiros MM, Ren Y, Wang P, DeMayo FJ, Frail DE, et al. Roles of NPM2 in 
chromatin and nucleolar organization in oocytes and embryos. Science 2003 Apr 
25;300(5619):633-636. 
(77) Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM. Zygote arrest 1 (Zar1) 
is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat Genet 2003 
Feb;33(2):187-191. 
(78) Wu X, Wang P, Brown CA, Zilinski CA, Matzuk MM. Zygote arrest 1 (Zar1) is an 
evolutionarily conserved gene expressed in vertebrate ovaries. Biol Reprod 2003 Sep;69(3):861-
867. 
(79) Hu J, Wang F, Zhu X, Yuan Y, Ding M, Gao S. Mouse ZAR1-like (XM_359149) 
colocalizes with mRNA processing components and its dominant-negative mutant caused two-
cell-stage embryonic arrest. Dev Dyn 2010 Feb;239(2):407-424. 
(80) Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 
2001 Aug 10;293(5532):1089-1093. 
(81) Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, et al. Genomic 
imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 2001 Mar 
23;104(6):829-838. 
(82) Hirasawa R, Chiba H, Kaneda M, Tajima S, Li E, Jaenisch R, et al. Maternal and zygotic 
Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during 
preimplantation development. Genes Dev 2008 Jun 15;22(12):1607-1616. 
(83) Payer B, Saitou M, Barton SC, Thresher R, Dixon JP, Zahn D, et al. Stella is a maternal 
effect gene required for normal early development in mice. Curr Biol 2003 Dec 2;13(23):2110-
2117. 
(84) Bortvin A, Goodheart M, Liao M, Page DC. Dppa3 / Pgc7 / stella is a maternal factor and is 
not required for germ cell specification in mice. BMC Dev Biol 2004 Feb 23;4:2. 
(85) Nakamura T, Arai Y, Umehara H, Masuhara M, Kimura T, Taniguchi H, et al. PGC7/Stella 
protects against DNA demethylation in early embryogenesis. Nat Cell Biol 2007 Jan;9(1):64-71. 
	  	   118	  
(86) Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect 
gene required for early embryonic development in mice. Nat Genet 2000 Nov;26(3):267-268 
